data_6jlt_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6jlt _Structure_validation_residue.Date_analyzed 2019-03-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.474 ' ND2' HE21 ' A' ' 62' ' ' GLN . 8.4 t30 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.474 HE21 ' ND2' ' A' ' 60' ' ' ASN . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.472 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.427 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HE ' HD13 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' H ' ' CD ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.4 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.493 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CD ' ' HZ1' ' A' ' 27' ' ' LYS . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t30 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t30 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.474 ' ND2' HE21 ' A' ' 62' ' ' GLN . 8.4 t30 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.474 HE21 ' ND2' ' A' ' 60' ' ' ASN . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.04 173.73 11.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -163.65 178.9 7.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 130.505 3.522 . . . . 0.0 103.971 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.434 ' CD2' ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -142.75 174.03 11.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' H ' ' CD2' ' A' ' 73' ' ' LEU . 22.5 ptt180 -72.9 -167.53 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.808 0.843 . . . . 0.0 111.063 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.94 -15.67 29.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.513 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.245 0.785 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.21 169.83 16.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -148.24 157.67 43.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.06 158.52 33.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.197 0.999 . . . . 0.0 109.578 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.79 -179.72 3.8 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.23 43.53 2.04 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.508 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.293 -1.837 . . . . 0.0 108.624 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.472 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 166.49 22.78 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -149.85 150.61 32.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.262 3.025 . . . . 0.0 103.649 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -154.01 174.01 15.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.164 0.986 . . . . 0.0 108.583 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 17.9 ptt180 -74.4 -167.71 0.57 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.787 1.235 . . . . 0.0 109.145 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.1 26.03 1.52 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.093 -1.949 . . . . 0.0 114.359 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-N 120.716 2.258 . . . . 0.0 110.473 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.63 150.13 31.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.36 101.54 0.51 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.3 177.96 1.33 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 129.258 3.023 . . . . 0.0 114.035 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -68.67 -177.47 0.97 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.53 73.81 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 117.631 -1.65 . . . . 0.0 114.829 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.427 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.47 169.06 11.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -167.55 156.9 10.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.247 3.019 . . . . 0.0 104.088 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.49 173.02 12.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.68 0.753 . . . . 0.0 110.698 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.34 171.55 1.03 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.385 1.474 . . . . 0.0 113.789 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.84 46.16 3.63 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.265 0.936 . . . . 0.0 112.211 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.88 163.32 22.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -164.36 142.34 6.91 Favored 'General case' 0 N--CA 1.446 -0.646 1 C-N-CA 131.825 4.05 . . . . 0.0 100.702 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -122.4 177.92 5.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.235 1.014 . . . . 0.0 113.631 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -70.76 -164.06 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.106 2.163 . . . . 0.0 110.48 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.68 21.9 0.73 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.074 1.797 . . . . 0.0 115.27 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HE ' HD13 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -131.4 159.66 37.34 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -167.46 152.63 7.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.977 2.911 . . . . 0.0 105.025 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -119.97 179.65 4.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' H ' ' CD2' ' A' ' 73' ' ' LEU . 25.4 ptt180 -75.32 -177.43 3.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.242 1.417 . . . . 0.0 109.249 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.41 29.0 1.99 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.071 -0.85 . . . . 0.0 114.292 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.795 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -81.06 145.79 30.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -151.26 147.34 26.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.7 -179.84 8.39 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.71 1.604 . . . . 0.0 107.816 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -66.76 168.61 9.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.443 0.697 . . . . 0.0 111.365 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.89 50.21 4.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.22 163.16 30.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -148.27 170.79 17.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.044 2.138 . . . . 0.0 106.7 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -166.57 168.3 14.72 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.944 1.298 . . . . 0.0 109.623 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 24.8 ptt180 -74.42 -175.09 2.22 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 109.62 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.79 71.19 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.22 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.51 154.73 51.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -157.71 165.09 36.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.175 1.39 . . . . 0.0 107.607 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.91 163.43 20.96 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.17 0.988 . . . . 0.0 110.526 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -74.73 170.52 15.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.67 45.31 3.49 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.575 -1.125 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' H ' ' CD ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.52 167.17 22.17 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -160.12 159.08 31.37 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 131.047 3.739 . . . . 0.0 102.927 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.89 -172.82 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.579 0.627 . . . . 0.0 112.079 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.14 173.11 2.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.273 1.029 . . . . 0.0 109.992 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.59 50.71 4.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.395 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.4 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.28 132.65 56.08 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -149.68 125.29 10.36 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.76 175.57 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 19.2 ptt180 -68.2 172.25 6.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.175 1.79 . . . . 0.0 109.112 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.77 -3.27 49.44 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.799 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.493 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.11 129.4 31.77 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.81 131.13 15.59 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.899 1.679 . . . . 0.0 107.963 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -132.26 -179.98 5.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.374 0.67 . . . . 0.0 112.649 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 30.1 ptt180 -68.81 171.65 7.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.582 1.553 . . . . 0.0 108.86 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.02 8.37 57.52 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 117.084 1.594 . . . . 0.0 117.084 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.47 158.35 22.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -169.11 109.53 0.47 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.118 2.967 . . . . 0.0 105.696 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.72 174.0 10.97 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 127.236 2.214 . . . . 0.0 112.29 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -66.4 -176.34 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.98 1.312 . . . . 0.0 111.352 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.12 -3.06 55.46 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.919 0 CA-C-N 120.119 1.96 . . . . 0.0 108.762 -179.811 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CD ' ' HZ1' ' A' ' 27' ' ' LYS . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -79.59 161.34 25.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -149.84 123.32 9.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 126.815 2.046 . . . . 0.0 106.358 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -144.94 175.76 9.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.453 1.501 . . . . 0.0 108.062 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' H ' ' CD1' ' A' ' 73' ' ' LEU . 21.4 ptt-85 -82.69 165.16 20.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.22 50.58 4.4 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 116.618 -2.212 . . . . 0.0 110.516 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp -121.6 162.67 20.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.15 124.07 28.36 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 155.28 50.45 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 118.583 0.629 . . . . 0.0 111.315 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -75.51 -172.32 1.78 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.988 1.715 . . . . 0.0 110.208 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.69 8.77 0.75 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 116.669 1.428 . . . . 0.0 116.669 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.635 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 179.517 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t30 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.97 161.29 26.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 94.93 2.68 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.19 152.72 21.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.02 -179.54 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.037 0.446 . . . . 0.0 110.876 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.04 26.25 0.8 Allowed Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.36 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.842 0 CA-C-N 120.648 2.224 . . . . 0.0 110.946 179.633 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.52 174.22 10.83 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -154.35 160.62 41.8 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.748 4.019 . . . . 0.0 102.294 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.73 171.18 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 120.205 1.366 . . . . 0.0 111.666 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -71.61 -178.55 2.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 109.69 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.55 11.16 5.76 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.249 -1.306 . . . . 0.0 115.036 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-N 120.198 1.999 . . . . 0.0 108.657 -179.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.82 160.26 38.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -158.66 150.14 20.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 129.415 3.086 . . . . 0.0 104.09 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.5 178.43 5.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -71.18 172.98 8.26 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.849 0.859 . . . . 0.0 109.63 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.14 2.55 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.707 0.67 . . . . 0.0 112.344 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 N-CA-C 107.324 -2.31 . . . . 0.0 107.324 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t30 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.72 158.97 33.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -156.01 125.72 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.853 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.09 159.32 40.15 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.954 0.902 . . . . 0.0 109.851 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ptt85 -82.52 173.13 12.25 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.13 55.31 4.57 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.598 -3.001 . . . . 0.0 105.598 179.448 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 26' ' ' VAL . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.7 pp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 ' HA ' HD12 ' A' ' 69' ' ' LEU . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 7' ' ' THR . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' N ' HG13 ' A' ' 17' ' ' VAL . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 55' ' ' THR . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HE ' HD11 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 26' ' ' VAL . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.56 ' H ' ' CD ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 6' ' ' LYS . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 41' ' ' ASN . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 55' ' ' THR . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' HD23 ' A' ' 56' ' ' LEU . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.463 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 26' ' ' VAL . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.7 pp -135.04 173.73 11.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -163.65 178.9 7.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 130.505 3.522 . . . . 0.0 103.971 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -142.75 174.03 11.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 73' ' ' LEU . 22.5 ptt180 -72.9 -167.53 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.808 0.843 . . . . 0.0 111.063 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.94 -15.67 29.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.513 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.44 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.245 0.785 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.21 169.83 16.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -148.24 157.67 43.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -159.06 158.52 33.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.197 0.999 . . . . 0.0 109.578 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -73.79 -179.72 3.8 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.23 43.53 2.04 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.508 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.293 -1.837 . . . . 0.0 108.624 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 166.49 22.78 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -149.85 150.61 32.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.262 3.025 . . . . 0.0 103.649 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -154.01 174.01 15.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.164 0.986 . . . . 0.0 108.583 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 73' ' ' LEU . 17.9 ptt180 -74.4 -167.71 0.57 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.787 1.235 . . . . 0.0 109.145 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.1 26.03 1.52 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.093 -1.949 . . . . 0.0 114.359 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-N 120.716 2.258 . . . . 0.0 110.473 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 ' HA ' HD12 ' A' ' 69' ' ' LEU . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 7' ' ' THR . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.63 150.13 31.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.36 101.54 0.51 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.3 177.96 1.33 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 129.258 3.023 . . . . 0.0 114.035 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -68.67 -177.47 0.97 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.53 73.81 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 117.631 -1.65 . . . . 0.0 114.829 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.47 169.06 11.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -167.55 156.9 10.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.247 3.019 . . . . 0.0 104.088 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.49 173.02 12.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.68 0.753 . . . . 0.0 110.698 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.34 171.55 1.03 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.385 1.474 . . . . 0.0 113.789 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.84 46.16 3.63 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.265 0.936 . . . . 0.0 112.211 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' N ' HG13 ' A' ' 17' ' ' VAL . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 55' ' ' THR . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.88 163.32 22.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -164.36 142.34 6.91 Favored 'General case' 0 N--CA 1.446 -0.646 1 C-N-CA 131.825 4.05 . . . . 0.0 100.702 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -122.4 177.92 5.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.235 1.014 . . . . 0.0 113.631 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -70.76 -164.06 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.106 2.163 . . . . 0.0 110.48 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.68 21.9 0.73 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.074 1.797 . . . . 0.0 115.27 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -179.852 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HE ' HD11 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -131.4 159.66 37.34 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -167.46 152.63 7.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.977 2.911 . . . . 0.0 105.025 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -119.97 179.65 4.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' H ' HD23 ' A' ' 73' ' ' LEU . 25.4 ptt180 -75.32 -177.43 3.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.242 1.417 . . . . 0.0 109.249 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.41 29.0 1.99 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.071 -0.85 . . . . 0.0 114.292 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.795 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -81.06 145.79 30.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -151.26 147.34 26.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.7 -179.84 8.39 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.71 1.604 . . . . 0.0 107.816 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -66.76 168.61 9.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.443 0.697 . . . . 0.0 111.365 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.89 50.21 4.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 26' ' ' VAL . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.22 163.16 30.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -148.27 170.79 17.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.044 2.138 . . . . 0.0 106.7 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -166.57 168.3 14.72 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.944 1.298 . . . . 0.0 109.623 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 24.8 ptt180 -74.42 -175.09 2.22 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 109.62 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.79 71.19 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.22 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.51 154.73 51.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -157.71 165.09 36.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.175 1.39 . . . . 0.0 107.607 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.1 OUTLIER -164.91 163.43 20.96 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.17 0.988 . . . . 0.0 110.526 -179.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.5 ptt-85 -74.73 170.52 15.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.67 45.31 3.49 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.575 -1.125 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.56 ' H ' ' CD ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 6' ' ' LYS . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.52 167.17 22.17 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -160.12 159.08 31.37 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 131.047 3.739 . . . . 0.0 102.927 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.89 -172.82 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.579 0.627 . . . . 0.0 112.079 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.14 173.11 2.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.273 1.029 . . . . 0.0 109.992 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.59 50.71 4.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.395 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.28 132.65 56.08 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -149.68 125.29 10.36 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.76 175.57 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 19.2 ptt180 -68.2 172.25 6.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.175 1.79 . . . . 0.0 109.112 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.77 -3.27 49.44 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.799 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.464 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.11 129.4 31.77 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.81 131.13 15.59 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.899 1.679 . . . . 0.0 107.963 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -132.26 -179.98 5.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.374 0.67 . . . . 0.0 112.649 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 30.1 ptt180 -68.81 171.65 7.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.582 1.553 . . . . 0.0 108.86 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.02 8.37 57.52 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 117.084 1.594 . . . . 0.0 117.084 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 41' ' ' ASN . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 55' ' ' THR . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.47 158.35 22.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -169.11 109.53 0.47 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.118 2.967 . . . . 0.0 105.696 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -76.72 174.0 10.97 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 127.236 2.214 . . . . 0.0 112.29 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' H ' HD23 ' A' ' 73' ' ' LEU . 13.0 ptt180 -66.4 -176.34 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.98 1.312 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.12 -3.06 55.46 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.919 0 CA-C-N 120.119 1.96 . . . . 0.0 108.762 -179.811 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -79.59 161.34 25.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -149.84 123.32 9.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 126.815 2.046 . . . . 0.0 106.358 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.94 175.76 9.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.453 1.501 . . . . 0.0 108.062 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -82.69 165.16 20.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.22 50.58 4.4 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 116.618 -2.212 . . . . 0.0 110.516 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp -121.6 162.67 20.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.15 124.07 28.36 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -134.25 155.28 50.45 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 118.583 0.629 . . . . 0.0 111.315 -178.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' H ' HD13 ' A' ' 73' ' ' LEU . 18.3 ptt180 -75.51 -172.32 1.78 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.988 1.715 . . . . 0.0 110.208 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.69 8.77 0.75 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 116.669 1.428 . . . . 0.0 116.669 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.635 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 179.517 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' HD23 ' A' ' 56' ' ' LEU . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.97 161.29 26.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 94.93 2.68 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -104.19 152.72 21.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.7 ptt180 -75.02 -179.54 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.037 0.446 . . . . 0.0 110.876 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.04 26.25 0.8 Allowed Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.36 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.842 0 CA-C-N 120.648 2.224 . . . . 0.0 110.946 179.633 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.52 174.22 10.83 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -154.35 160.62 41.8 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.748 4.019 . . . . 0.0 102.294 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.6 OUTLIER -135.73 171.18 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 120.205 1.366 . . . . 0.0 111.666 -177.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 73' ' ' LEU . 4.3 ptt180 -71.61 -178.55 2.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 109.69 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.55 11.16 5.76 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.249 -1.306 . . . . 0.0 115.036 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-N 120.198 1.999 . . . . 0.0 108.657 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.82 160.26 38.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -158.66 150.14 20.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 129.415 3.086 . . . . 0.0 104.09 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.5 178.43 5.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -71.18 172.98 8.26 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.849 0.859 . . . . 0.0 109.63 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.14 2.55 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.707 0.67 . . . . 0.0 112.344 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 N-CA-C 107.324 -2.31 . . . . 0.0 107.324 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.72 158.97 33.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -156.01 125.72 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.853 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -155.09 159.32 40.15 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.954 0.902 . . . . 0.0 109.851 178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' H ' HD13 ' A' ' 73' ' ' LEU . 41.4 ptt85 -82.52 173.13 12.25 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.13 55.31 4.57 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.598 -3.001 . . . . 0.0 105.598 179.448 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 26' ' ' VAL . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' HE22 ' A' ' 62' ' ' GLN . 8.4 t30 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.484 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.7 pp . . . . . 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 ' HA ' HD12 ' A' ' 69' ' ' LEU . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 7' ' ' THR . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' N ' HG13 ' A' ' 17' ' ' VAL . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 55' ' ' THR . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HE ' HD11 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 26' ' ' VAL . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG2' HE21 ' A' ' 31' ' ' GLN . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 27' ' ' LYS . 75.6 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.56 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 6' ' ' LYS . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.4 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.525 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 41' ' ' ASN . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 55' ' ' THR . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t30 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' HD23 ' A' ' 56' ' ' LEU . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.463 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t30 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -131.53 150.42 52.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.14 160.86 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -105.32 153.82 21.11 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.146 0.979 . . . . 0.0 108.362 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 t -140.38 115.33 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.123 0.969 . . . . 0.0 108.812 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -81.58 129.61 34.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -87.95 171.16 10.53 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.766 0.826 . . . . 0.0 111.72 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 mt -69.06 -20.44 64.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.595 1.158 . . . . 0.0 109.563 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -86.18 -1.09 57.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.154 1.781 . . . . 0.0 110.66 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.45 8.3 86.4 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.623 1.582 . . . . 0.0 112.424 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -82.94 173.7 11.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.277 1.831 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 m -135.25 135.88 41.26 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.7 mt -128.5 151.43 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 126.224 1.809 . . . . 0.0 106.262 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -114.34 145.3 41.97 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -134.09 154.08 51.41 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.9 123.62 48.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.27 167.49 15.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 125.568 1.547 . . . . 0.0 110.825 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -123.44 161.47 45.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 -41.0 75.19 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 113.744 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -83.05 -7.67 59.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.17 132.44 49.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.7 p -78.75 161.37 26.89 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.5 mm -56.94 -20.51 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.902 0.481 . . . . 0.0 110.393 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -58.64 -47.66 83.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -58.47 -49.69 76.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 124.464 1.106 . . . . 0.0 110.181 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 26' ' ' VAL . 4.0 t -58.24 -49.3 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.556 1.142 . . . . 0.0 109.256 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -59.13 -47.68 84.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.202 1.801 . . . . 0.0 108.507 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.02 87.36 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.769 1.227 . . . . 0.0 111.133 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.88 -38.52 91.26 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 117.313 -1.327 . . . . 0.0 111.514 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -74.16 -39.41 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.318 1.417 . . . . 0.0 108.986 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.66 -41.65 73.96 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.025 0.829 . . . . 0.0 109.09 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.55 -4.84 2.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.094 2.157 . . . . 0.0 113.85 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -135.94 2.36 2.84 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.24 -33.04 3.12 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.043 0.937 . . . . 0.0 112.0 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.49 66.56 2.25 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -142.09 158.92 60.62 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.163 1.385 . . . . 0.0 108.006 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -80.46 162.71 22.09 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.449 2.099 . . . . 0.0 111.254 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.43 3.68 0.59 Allowed 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.48 3.453 . . . . 0.0 114.18 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -122.12 163.39 19.58 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.362 2.665 . . . . 0.0 108.827 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 62.44 25.73 15.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.826 0.85 . . . . 0.0 111.96 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -157.92 148.05 20.36 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 120.784 -1.197 . . . . 0.0 109.892 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -153.3 157.28 39.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.128 1.371 . . . . 0.0 109.188 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.69 150.58 28.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.423 1.089 . . . . 0.0 109.137 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.0 mm -133.24 154.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 126.831 2.052 . . . . 0.0 106.269 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -136.75 103.42 5.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.03 55.41 8.7 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.654 1.581 . . . . 0.0 109.717 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.24 -15.11 9.41 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.174 1.369 . . . . 0.0 114.491 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -76.8 128.68 35.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 120.583 2.192 . . . . 0.0 107.94 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.25 135.65 37.61 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -122.0 149.44 43.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.119 1.368 . . . . 0.0 108.31 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.24 169.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.543 0.737 . . . . 0.0 109.4 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -69.37 146.64 51.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.764 0.792 . . . . 0.0 110.222 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.54 -10.33 8.1 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 117.586 -1.675 . . . . 0.0 114.216 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -135.09 177.76 7.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.442 2.121 . . . . 0.0 112.262 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 69.5 p -98.61 167.86 10.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.596 1.558 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -35.37 80.5 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -66.01 -42.7 89.35 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.435 1.894 . . . . 0.0 110.844 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -57.86 -39.55 78.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.398 0.999 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.6 -6.65 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' HE22 ' A' ' 62' ' ' GLN . 8.4 t30 53.26 70.33 0.6 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.719 2.408 . . . . 0.0 108.688 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.3 111.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.393 1.477 . . . . 0.0 108.225 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.484 HE22 ' ND2' ' A' ' 60' ' ' ASN . 3.8 mp0 -79.08 176.47 9.63 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -67.7 165.21 17.66 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.25 -0.907 . . . . 0.0 109.461 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 48.66 37.17 8.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.276 1.83 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.12 168.75 18.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -133.47 92.64 3.02 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.74 164.48 23.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.586 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -130.41 138.78 50.51 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.41 120.24 36.35 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.01 1.724 . . . . 0.0 107.09 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.2 169.93 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.622 1.169 . . . . 0.0 107.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 71' ' ' LEU . 3.7 pp -135.04 173.73 11.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.17 0.986 . . . . 0.0 112.263 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -163.65 178.9 7.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 130.505 3.522 . . . . 0.0 103.971 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -142.75 174.03 11.02 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 73' ' ' LEU . 22.5 ptt180 -72.9 -167.53 0.39 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.808 0.843 . . . . 0.0 111.063 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.94 -15.67 29.11 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.513 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.44 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.245 0.785 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -143.02 156.96 44.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.53 155.07 13.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.31 152.78 18.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -138.28 121.54 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.248 1.019 . . . . 0.0 108.816 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.98 126.77 35.86 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.6 p -85.49 171.24 11.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.714 0.806 . . . . 0.0 111.722 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.67 -24.76 65.46 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -78.48 2.53 18.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.438 1.895 . . . . 0.0 110.681 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.72 7.4 80.05 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 126.932 2.206 . . . . 0.0 112.645 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -79.69 167.92 20.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.895 1.678 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -128.65 137.9 51.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.1 mt -131.91 153.06 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.781 1.632 . . . . 0.0 106.928 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -114.58 137.9 51.31 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.5 mt -124.84 146.09 49.45 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -97.89 124.12 42.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.5 176.78 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.581 1.552 . . . . 0.0 110.17 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -140.67 158.49 65.54 Favored Pre-proline 0 N--CA 1.453 -0.296 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.52 -37.99 94.48 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.034 2.489 . . . . 0.0 115.917 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.71 -8.89 55.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.633 1.173 . . . . 0.0 112.706 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.14 137.01 54.57 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -76.19 159.29 30.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -59.99 -19.34 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.003 0.521 . . . . 0.0 110.628 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.66 -40.2 96.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -60.23 -49.43 77.64 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.631 1.173 . . . . 0.0 108.626 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -59.29 -45.78 92.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.044 1.338 . . . . 0.0 109.634 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -65.45 -33.88 76.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.54 0.736 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.49 66.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.682 1.193 . . . . 0.0 109.725 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.72 -30.06 71.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 126.611 1.965 . . . . 0.0 112.755 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.7 tp -79.84 -40.98 21.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -57.53 -35.01 69.73 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.837 0.855 . . . . 0.0 110.431 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -8.11 1.92 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.025 2.13 . . . . 0.0 112.234 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -132.33 -28.34 1.69 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.383 1.873 . . . . 0.0 112.762 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -99.46 -17.19 18.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 -19.0 0.21 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 126.157 1.837 . . . . 0.0 116.619 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.83 157.41 15.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 111.159 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.98 171.03 14.63 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.096 1.864 . . . . 0.0 110.27 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.88 -18.09 63.0 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.832 2.355 . . . . 0.0 111.876 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.72 162.16 18.03 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.144 1.378 . . . . 0.0 108.966 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 56.85 26.31 11.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.415 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -165.89 149.02 7.56 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.02 -1.05 . . . . 0.0 111.386 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -165.42 156.2 13.8 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.895 1.278 . . . . 0.0 110.298 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.96 158.86 15.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.334 1.053 . . . . 0.0 109.588 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mm -141.51 155.17 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.276 2.23 . . . . 0.0 106.534 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -138.31 100.22 4.06 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.89 61.3 2.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.838 2.055 . . . . 0.0 108.871 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.43 -20.67 3.24 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.41 1.481 . . . . 0.0 115.124 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -66.87 129.83 41.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 120.228 2.014 . . . . 0.0 108.263 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -78.63 120.06 22.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -108.97 146.14 34.34 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 118.562 0.619 . . . . 0.0 110.634 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.31 167.79 26.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.074 0.95 . . . . 0.0 109.849 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.51 153.1 43.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.768 1.227 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.01 -2.18 25.62 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.103 1.335 . . . . 0.0 111.719 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -139.69 -175.12 4.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 127.346 2.258 . . . . 0.0 111.335 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.7 p -125.24 174.73 7.91 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.767 2.027 . . . . 0.0 109.346 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -36.57 84.12 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.767 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -33.4 70.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.536 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.08 -19.5 64.87 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.723 1.147 . . . . 0.0 111.123 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.91 0.11 29.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.922 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 46.18 69.05 0.51 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.283 2.233 . . . . 0.0 109.423 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -108.06 108.81 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 112.619 -2.082 . . . . 0.0 105.8 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.69 161.52 30.67 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.32 163.56 26.29 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.0 27.61 9.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.335 1.454 . . . . 0.0 112.538 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -69.08 -176.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.001 2.12 . . . . 0.0 110.914 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.87 91.76 2.73 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.7 164.42 23.74 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -127.55 161.01 29.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.83 126.2 44.12 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.34 178.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.21 169.83 16.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.257 1.027 . . . . 0.0 110.194 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -148.24 157.67 43.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.49 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -159.06 158.52 33.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.197 0.999 . . . . 0.0 109.578 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -73.79 -179.72 3.8 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.23 43.53 2.04 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.508 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.293 -1.837 . . . . 0.0 108.624 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 mtt . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.305 0.574 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -145.26 154.52 42.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 168.01 8.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -108.98 152.31 25.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -137.65 121.76 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.78 127.37 37.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -89.21 162.02 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.05 0.94 . . . . 0.0 109.435 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.35 -27.1 69.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.308 1.043 . . . . 0.0 110.924 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 p -72.28 -8.69 56.22 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.757 1.223 . . . . 0.0 111.119 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.98 33.25 15.62 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.811 1.672 . . . . 0.0 111.57 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -113.62 164.48 13.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.083 1.441 . . . . 0.0 108.963 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -124.34 134.38 53.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.9 mt -122.84 157.41 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.702 2.001 . . . . 0.0 105.881 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.6 m -122.57 144.47 49.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.308 1.443 . . . . 0.0 107.536 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -134.82 156.46 48.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -107.06 121.76 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.51 173.4 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.717 1.607 . . . . 0.0 111.405 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.49 158.18 63.99 Favored Pre-proline 0 N--CA 1.452 -0.352 0 O-C-N 121.461 -0.775 . . . . 0.0 110.271 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.31 -36.6 87.31 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.027 2.485 . . . . 0.0 114.996 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.13 -13.54 55.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 112.11 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.7 130.96 45.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.611 1.096 . . . . 0.0 109.027 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 p -74.3 158.72 33.5 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mm -57.45 -22.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -56.29 -50.14 72.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.172 1.789 . . . . 0.0 107.718 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -59.26 -50.56 73.52 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.907 1.283 . . . . 0.0 109.639 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.8 -44.76 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 124.709 1.204 . . . . 0.0 109.528 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -68.93 -36.27 77.76 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.168 0.987 . . . . 0.0 109.649 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.31 -40.46 74.2 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.188 0.904 . . . . 0.0 110.368 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -63.17 -34.31 77.34 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.227 1.411 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.75 -39.17 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 119.868 1.213 . . . . 0.0 107.877 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -58.02 -38.94 77.16 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.905 0.775 . . . . 0.0 109.559 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.43 0.26 1.1 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.763 2.025 . . . . 0.0 112.567 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -138.46 3.51 2.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.327 2.251 . . . . 0.0 111.37 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -133.84 -25.45 1.63 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.74 -17.72 4.28 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 116.865 1.506 . . . . 0.0 116.865 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.46 157.87 80.67 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.256 1.528 . . . . 0.0 109.971 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.28 172.41 16.31 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.369 2.046 . . . . 0.0 110.995 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.1 -14.44 45.21 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.836 2.357 . . . . 0.0 112.706 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -93.82 174.41 7.19 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.598 2.359 . . . . 0.0 107.098 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 59.72 16.52 5.58 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 120.318 -1.489 . . . . 0.0 111.208 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -163.26 151.44 13.67 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.381 1.872 . . . . 0.0 108.8 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 142.82 19.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -87.07 144.92 26.66 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.032 0.933 . . . . 0.0 110.238 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -137.96 153.2 27.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.513 1.925 . . . . 0.0 106.594 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -141.01 111.48 6.86 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.792 2.437 . . . . 0.0 106.015 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.46 52.42 10.84 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.942 0.897 . . . . 0.0 110.605 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.0 -15.04 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.179 1.371 . . . . 0.0 114.621 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -76.25 124.33 27.31 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 120.227 2.013 . . . . 0.0 106.066 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -79.48 139.7 37.54 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.5 mt -125.05 158.07 34.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.163 1.385 . . . . 0.0 107.878 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -161.77 167.2 25.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.362 0.665 . . . . 0.0 109.407 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.27 129.35 37.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.454 0.645 . . . . 0.0 109.275 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.39 -12.96 0.59 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 127.611 2.529 . . . . 0.0 112.779 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -135.33 -162.97 1.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.22 1.808 . . . . 0.0 112.996 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.9 p -120.86 176.33 5.6 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.202 1.801 . . . . 0.0 111.297 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.21 -39.03 78.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -67.65 -39.82 84.56 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.67 -55.2 37.07 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.657 1.183 . . . . 0.0 110.524 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -67.98 -4.96 14.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t30 49.1 73.65 0.22 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.403 2.681 . . . . 0.0 111.348 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -113.58 146.11 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -98.36 158.46 15.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.117 1.767 . . . . 0.0 109.831 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.83 163.89 8.78 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 45.19 40.97 5.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.186 1.394 . . . . 0.0 111.929 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.53 175.15 10.61 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.925 0.89 . . . . 0.0 108.96 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 m -130.86 110.19 11.12 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -99.56 167.67 10.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.565 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -133.06 161.91 33.12 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.927 1.291 . . . . 0.0 108.921 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.0 mt -124.68 117.48 24.35 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.797 1.639 . . . . 0.0 107.491 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.14 153.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 166.49 22.78 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 123.878 1.799 . . . . 0.0 113.254 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -149.85 150.61 32.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 129.262 3.025 . . . . 0.0 103.649 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -154.01 174.01 15.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.164 0.986 . . . . 0.0 108.583 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 73' ' ' LEU . 17.9 ptt180 -74.4 -167.71 0.57 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.787 1.235 . . . . 0.0 109.145 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.1 26.03 1.52 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.093 -1.949 . . . . 0.0 114.359 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-N 120.716 2.258 . . . . 0.0 110.473 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 mtt . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -134.74 154.64 51.49 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.73 162.79 8.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.331 1.852 . . . . 0.0 106.08 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.01 146.16 28.77 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.95 120.06 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.405 0.682 . . . . 0.0 109.457 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -88.69 127.25 35.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.326 -0.845 . . . . 0.0 108.878 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 ' HA ' HD12 ' A' ' 69' ' ' LEU . 72.9 p -92.25 156.1 17.52 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.89 -22.72 49.72 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.634 0.652 . . . . 0.0 112.598 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.49 -6.08 28.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 7.68 66.8 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 127.155 2.312 . . . . 0.0 113.49 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -91.92 168.3 11.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.893 1.677 . . . . 0.0 111.174 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.11 141.43 50.13 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.0 mt -127.84 163.43 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 127.862 2.465 . . . . 0.0 106.639 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -122.01 148.33 44.95 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.22 171.11 14.98 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -121.58 123.18 41.35 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.08 179.18 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 127.059 2.144 . . . . 0.0 111.316 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -147.76 161.52 34.91 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.307 1.443 . . . . 0.0 108.938 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -55.75 -38.32 94.52 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.355 2.704 . . . . 0.0 115.201 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -87.05 -8.05 57.49 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.063 0.847 . . . . 0.0 112.978 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.3 122.59 17.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -65.84 159.22 25.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.37 -18.18 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 121.293 -0.879 . . . . 0.0 109.33 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -65.97 -49.1 69.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.649 1.98 . . . . 0.0 106.655 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -60.57 -45.68 93.04 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.39 1.876 . . . . 0.0 108.74 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.24 -44.01 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -65.49 -37.5 87.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.372 0.669 . . . . 0.0 109.442 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.27 91.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.976 0.91 . . . . 0.0 109.911 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -62.45 -36.38 82.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.499 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.08 -41.02 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.581 1.082 . . . . 0.0 109.588 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -52.63 -38.76 60.85 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.955 0.902 . . . . 0.0 110.688 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.4 -27.29 15.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.391 1.476 . . . . 0.0 112.354 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -111.06 -30.57 7.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.44 1.496 . . . . 0.0 112.016 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -75.96 -35.09 59.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.384 1.073 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.51 50.58 42.52 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.208 0.913 . . . . 0.0 112.82 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -141.31 160.65 56.55 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.29 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -85.67 172.55 7.83 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.2 2.6 . . . . 0.0 108.958 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.11 -13.75 5.24 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.868 3.045 . . . . 0.0 116.862 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.8 159.42 15.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 111.354 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 67.94 17.75 9.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.924 1.29 . . . . 0.0 111.21 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -163.6 125.74 2.48 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -135.82 152.5 51.14 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.354 1.862 . . . . 0.0 108.899 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.4 145.04 24.77 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.733 1.613 . . . . 0.0 107.946 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -133.12 99.18 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.653 1.581 . . . . 0.0 110.679 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -82.6 101.6 10.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.408 1.083 . . . . 0.0 108.388 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.05 48.46 15.57 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.359 1.063 . . . . 0.0 110.44 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.55 -21.31 22.69 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.586 -1.119 . . . . 0.0 114.379 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -69.16 123.56 21.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.732 1.766 . . . . 0.0 108.326 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -78.9 133.42 36.95 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.6 mt -122.33 138.14 54.61 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.009 0.924 . . . . 0.0 109.836 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.43 173.69 13.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.62 1.168 . . . . 0.0 108.966 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.06 173.28 0.83 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.95 0.69 90.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.323 1.44 . . . . 0.0 114.383 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -137.78 -178.65 5.34 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.931 1.366 . . . . 0.0 109.803 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -120.23 171.03 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.655 1.182 . . . . 0.0 111.546 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.36 -34.1 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.092 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.69 -33.37 53.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.466 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -65.24 -37.29 86.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.041 1.291 . . . . 0.0 108.594 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -83.34 -0.26 48.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.084 0.554 . . . . 0.0 110.548 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.1 t30 43.05 71.38 0.23 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.357 3.063 . . . . 0.0 111.377 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -110.31 138.39 38.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -99.67 161.76 13.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.0 1.32 . . . . 0.0 108.221 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -65.95 169.02 7.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.844 0.831 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 52.69 18.85 1.09 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.673 2.389 . . . . 0.0 113.518 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 p -72.09 176.64 4.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.687 0.795 . . . . 0.0 110.845 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.7 m -125.8 120.43 30.53 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.81 121.69 45.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.47 143.72 27.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 7' ' ' THR . 47.3 mt -102.24 127.65 49.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.26 139.09 48.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.63 150.13 31.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -167.36 101.54 0.51 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.3 177.96 1.33 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 129.258 3.023 . . . . 0.0 114.035 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -68.67 -177.47 0.97 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.619 1.568 . . . . 0.0 110.611 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.53 73.81 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 117.631 -1.65 . . . . 0.0 114.829 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtt . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -91.21 152.07 20.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.14 156.46 30.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -97.61 155.02 17.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.02 110.04 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.813 1.645 . . . . 0.0 107.949 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -79.56 133.41 36.46 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -109.08 159.42 16.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.905 0.882 . . . . 0.0 112.435 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.8 mt -60.3 -22.72 63.49 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.85 1.26 . . . . 0.0 111.297 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.5 p -74.16 2.39 9.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.587 1.555 . . . . 0.0 110.653 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.44 39.27 80.35 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.338 1.923 . . . . 0.0 109.42 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt -128.9 -179.14 4.93 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.725 1.21 . . . . 0.0 110.668 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -134.39 141.22 46.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.89 160.9 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 128.609 2.764 . . . . 0.0 105.939 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 m -125.67 136.47 53.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.1 mt -132.95 160.35 37.33 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -124.71 128.13 48.33 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.41 -174.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.063 2.145 . . . . 0.0 110.766 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -139.72 157.64 69.51 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -55.74 -39.7 89.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.108 2.539 . . . . 0.0 114.656 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.93 -5.0 59.35 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.007 -0.997 . . . . 0.0 113.363 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.96 132.23 48.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.312 1.414 . . . . 0.0 108.76 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -73.91 155.65 38.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.94 -14.33 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.748 0.819 . . . . 0.0 110.728 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.27 -48.75 80.42 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.29 -48.99 79.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 126.19 1.796 . . . . 0.0 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.97 -43.36 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 124.449 1.1 . . . . 0.0 109.248 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -67.65 -27.87 67.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.238 1.015 . . . . 0.0 109.508 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -46.11 19.28 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.946 . . . . 0.0 110.071 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -57.31 -37.9 73.18 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.461 1.904 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.38 -49.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.218 -0.896 . . . . 0.0 108.794 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.01 -36.21 27.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.502 1.121 . . . . 0.0 111.974 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -53.99 -35.73 62.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.824 1.25 . . . . 0.0 111.908 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -108.9 -31.95 7.47 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.354 1.462 . . . . 0.0 113.306 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -74.24 -33.37 63.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.042 0.937 . . . . 0.0 110.921 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.06 43.05 96.3 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.705 0.684 . . . . 0.0 113.595 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.19 162.96 47.12 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.443 1.497 . . . . 0.0 107.324 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.29 171.33 17.14 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.902 1.735 . . . . 0.0 111.283 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -61.85 -29.56 82.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 122.43 2.087 . . . . 0.0 108.537 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -86.15 177.67 7.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.781 2.433 . . . . 0.0 107.517 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.95 13.68 5.78 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.056 -1.652 . . . . 0.0 112.757 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.19 134.22 7.27 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 119.897 -1.752 . . . . 0.0 110.308 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.7 33.29 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.33 152.56 21.46 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 108.471 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 mm -135.8 154.57 34.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.05 -27.94 3.5 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 121.822 2.101 . . . . 0.0 116.071 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -172.83 55.52 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.84 16.64 74.64 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.876 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -117.76 124.1 47.61 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -78.99 147.25 32.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.53 124.0 41.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.209 1.403 . . . . 0.0 108.037 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.13 164.49 26.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.877 1.271 . . . . 0.0 108.252 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -68.6 162.24 26.29 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.15 0.976 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.87 -8.73 56.3 Favored Glycine 0 CA--C 1.537 1.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' A' ' 58' ' ' ASP . 10.4 mmt180 -118.19 179.94 3.95 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.344 2.258 . . . . 0.0 108.561 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -130.51 177.76 7.12 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.125 1.77 . . . . 0.0 108.57 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 -37.97 80.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -38.84 83.44 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.547 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB3' HH11 ' A' ' 54' ' ' ARG . 83.6 m-20 -64.03 -30.93 71.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.231 0.923 . . . . 0.0 110.211 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.49 -0.12 57.38 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.024 0.375 . . . . 0.0 110.871 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 t30 46.81 65.56 1.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.49 2.316 . . . . 0.0 109.623 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.64 134.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.054 1.742 . . . . 0.0 107.95 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -90.57 162.88 14.8 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 108.53 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -73.23 163.88 27.48 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 48.97 34.76 5.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.437 1.495 . . . . 0.0 111.795 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -74.26 -178.3 3.37 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.089 1.355 . . . . 0.0 111.153 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -139.29 94.69 2.83 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -79.83 147.81 31.62 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.703 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.65 134.1 52.35 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 mt -101.04 134.34 44.19 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.48 165.94 20.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.47 169.06 11.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.991 0.9 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -167.55 156.9 10.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.247 3.019 . . . . 0.0 104.088 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.49 173.02 12.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.68 0.753 . . . . 0.0 110.698 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.34 171.55 1.03 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.385 1.474 . . . . 0.0 113.789 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.84 46.16 3.63 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.265 0.936 . . . . 0.0 112.211 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 N-CA-C 105.865 -2.894 . . . . 0.0 105.865 179.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -138.33 150.49 46.65 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 160.3 31.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.529 1.132 . . . . 0.0 108.13 177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -103.81 146.19 28.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -134.48 117.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.629 1.172 . . . . 0.0 108.813 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.96 140.74 32.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.1 p -105.61 164.38 11.95 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.127 0.971 . . . . 0.0 111.783 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.1 mt -64.41 -22.81 67.08 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.652 1.181 . . . . 0.0 109.906 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.6 p -75.4 -3.64 34.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.549 1.14 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.0 21.19 63.59 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 125.786 1.66 . . . . 0.0 111.354 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -103.35 174.59 5.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.682 1.593 . . . . 0.0 110.083 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -134.0 136.37 44.06 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.6 mt -120.83 157.01 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.828 2.451 . . . . 0.0 106.749 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 m -124.28 133.09 53.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.2 155.96 39.21 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.569 0.748 . . . . 0.0 109.083 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -99.69 139.56 35.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -143.07 -170.17 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-O 124.884 2.278 . . . . 0.0 111.637 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' N ' HG13 ' A' ' 17' ' ' VAL . 67.5 mm-40 -153.73 159.8 31.66 Favored Pre-proline 0 C--N 1.305 -1.356 1 CA-C-N 107.876 -4.238 . . . . 0.0 111.422 -178.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.94 -38.09 1.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 124.272 3.315 . . . . 0.0 111.817 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.15 -1.16 56.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.078 0.854 . . . . 0.0 112.988 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.9 124.57 25.16 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -67.55 156.54 36.49 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -56.02 -22.75 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.79 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -67.12 -33.31 75.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.389 0.995 . . . . 0.0 109.895 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -68.95 -49.47 57.67 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 t -58.74 -34.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.157 1.783 . . . . 0.0 108.518 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.29 -38.1 60.55 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.141 1.377 . . . . 0.0 108.661 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.43 88.05 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -60.23 -37.12 79.38 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 126.304 1.842 . . . . 0.0 111.807 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.64 -41.3 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.713 1.142 . . . . 0.0 108.527 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.0 -32.09 67.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.414 1.007 . . . . 0.0 110.244 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.0 -10.55 14.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 112.367 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -136.1 8.54 3.21 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.579 1.951 . . . . 0.0 111.631 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -123.29 -33.52 3.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.776 1.23 . . . . 0.0 111.105 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.08 45.77 95.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.301 0.953 . . . . 0.0 114.358 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.29 161.06 65.62 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.936 1.294 . . . . 0.0 108.88 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.75 161.5 43.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.647 2.231 . . . . 0.0 111.54 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.86 -32.63 95.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.317 2.011 . . . . 0.0 111.499 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -74.36 150.37 40.12 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.711 2.004 . . . . 0.0 110.616 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.41 20.21 8.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.133 1.373 . . . . 0.0 110.362 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -154.2 158.64 40.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -172.64 158.07 4.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.908 1.283 . . . . 0.0 111.524 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.84 151.77 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.553 1.541 . . . . 0.0 109.465 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -141.04 147.08 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.049 2.14 . . . . 0.0 106.447 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -141.36 103.53 4.43 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.0 57.85 6.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.22 1.408 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.13 -18.14 2.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.753 1.644 . . . . 0.0 115.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -71.5 126.15 28.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.223 2.012 . . . . 0.0 108.63 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.53 120.06 23.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 mt -100.43 136.08 40.87 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.13 0.572 . . . . 0.0 109.477 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -148.75 174.86 11.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.63 1.172 . . . . 0.0 109.152 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.5 177.31 0.53 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.873 1.269 . . . . 0.0 114.105 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.93 71.81 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.229 0.918 . . . . 0.0 113.677 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -131.47 176.8 8.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 128.698 2.799 . . . . 0.0 109.307 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 69.9 p -128.21 170.84 12.54 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.4 1.88 . . . . 0.0 108.395 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -33.86 76.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.229 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -76.54 -36.02 57.93 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.063 0.945 . . . . 0.0 110.352 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 55' ' ' THR . 55.1 m-20 -62.51 -43.91 97.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.42 -8.66 58.07 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.865 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 t30 50.95 73.55 0.28 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.951 2.101 . . . . 0.0 108.247 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.39 120.99 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -80.61 162.11 24.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -68.95 162.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.046 0.451 . . . . 0.0 109.849 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 50.02 33.63 7.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.69 1.596 . . . . 0.0 111.237 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.71 175.76 5.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.096 1.758 . . . . 0.0 109.348 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -124.7 84.46 2.28 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.87 156.63 28.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.54 157.8 40.2 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 108.913 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.55 133.82 55.57 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.72 -175.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 127.573 2.349 . . . . 0.0 105.866 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.88 163.32 22.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.9 0.857 . . . . 0.0 111.712 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -164.36 142.34 6.91 Favored 'General case' 0 N--CA 1.446 -0.646 1 C-N-CA 131.825 4.05 . . . . 0.0 100.702 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 mt -122.4 177.92 5.19 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.235 1.014 . . . . 0.0 113.631 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -70.76 -164.06 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.106 2.163 . . . . 0.0 110.48 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.68 21.9 0.73 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.074 1.797 . . . . 0.0 115.27 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 -179.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -129.53 153.96 47.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 120.073 1.306 . . . . 0.0 109.253 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.04 165.7 6.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 126.461 1.904 . . . . 0.0 106.911 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -110.92 140.85 45.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.63 116.59 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.502 1.521 . . . . 0.0 108.712 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -81.1 138.4 35.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.0 p -98.17 165.22 11.99 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.736 0.814 . . . . 0.0 110.888 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.27 -29.12 69.87 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.2 p -70.83 -3.87 21.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.805 1.242 . . . . 0.0 110.922 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.14 19.03 63.54 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.819 1.676 . . . . 0.0 112.604 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -95.68 172.48 8.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.094 1.358 . . . . 0.0 109.324 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -130.02 136.11 49.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -128.17 148.72 32.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -111.02 141.83 43.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -130.99 175.24 9.24 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.59 124.04 32.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -143.3 169.94 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 127.394 2.278 . . . . 0.0 109.189 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -131.54 157.38 78.31 Favored Pre-proline 0 C--N 1.331 -0.236 0 O-C-N 121.533 -0.729 . . . . 0.0 109.19 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.71 -34.57 91.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.361 2.707 . . . . 0.0 114.619 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 t -80.29 -15.4 57.03 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.563 1.145 . . . . 0.0 111.686 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -66.91 139.11 57.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.705 1.139 . . . . 0.0 110.377 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.0 p -78.36 160.39 27.84 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.26 -26.46 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 122.173 -0.329 . . . . 0.0 111.754 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.38 -34.15 73.48 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.512 0.596 . . . . 0.0 109.805 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -64.65 -48.93 72.99 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -57.2 -47.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.926 1.29 . . . . 0.0 108.391 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.82 -36.11 82.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.328 1.051 . . . . 0.0 110.111 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.39 -46.93 65.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.122 0.969 . . . . 0.0 110.102 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -62.88 -28.3 69.94 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.566 1.946 . . . . 0.0 113.324 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.94 -40.94 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -61.29 -28.63 69.33 Favored 'General case' 0 C--N 1.342 0.243 0 O-C-N 121.774 -0.579 . . . . 0.0 109.881 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -62.36 -6.32 3.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.328 1.851 . . . . 0.0 112.509 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -132.61 -31.14 1.38 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.261 1.824 . . . . 0.0 111.16 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -82.06 -33.27 29.98 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.193 0.597 . . . . 0.0 110.258 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.41 58.44 14.38 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.413 1.006 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -141.64 155.67 66.63 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 125.168 1.387 . . . . 0.0 108.849 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.74 157.08 53.85 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.393 2.062 . . . . 0.0 112.036 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 -21.08 64.73 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.291 2.661 . . . . 0.0 113.715 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.88 161.13 16.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.161 2.184 . . . . 0.0 109.753 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 62.22 30.07 17.55 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.996 1.379 . . . . 0.0 109.754 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.54 154.31 28.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HE ' HD11 ' A' ' 44' ' ' ILE . 23.0 ttt180 -164.18 138.2 5.49 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.659 1.183 . . . . 0.0 108.191 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.8 150.22 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.483 1.113 . . . . 0.0 108.549 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 HD11 ' HE ' ' A' ' 42' ' ' ARG . 35.3 mm -145.1 146.19 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.514 1.526 . . . . 0.0 107.957 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.03 100.8 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.79 57.57 4.98 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.365 1.866 . . . . 0.0 109.991 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.79 -15.18 6.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.775 1.655 . . . . 0.0 115.347 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 127.04 31.32 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.936 2.368 . . . . 0.0 108.218 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -79.3 101.56 8.13 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.649 1.579 . . . . 0.0 109.761 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.6 mt -84.34 126.06 32.86 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.36 1.064 . . . . 0.0 109.753 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -150.3 175.47 11.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.709 1.204 . . . . 0.0 108.956 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -64.67 173.44 2.2 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.88 -3.87 86.58 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.297 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -132.53 -179.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.583 1.953 . . . . 0.0 111.66 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -124.97 173.77 8.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.412 2.285 . . . . 0.0 109.175 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -34.86 78.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.71 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 t -70.45 -40.35 73.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.58 -18.78 65.19 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -105.34 1.07 27.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.705 0.684 . . . . 0.0 111.547 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 47.67 65.52 1.26 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.794 2.037 . . . . 0.0 110.486 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.7 mt -106.38 112.45 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.55 167.08 22.22 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.32 167.72 11.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.418 0.687 . . . . 0.0 109.342 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 52.1 24.59 2.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.439 1.896 . . . . 0.0 113.857 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.28 174.55 1.18 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.851 1.26 . . . . 0.0 110.949 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -135.23 92.3 2.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.04 158.3 23.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.679 1.192 . . . . 0.0 109.298 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.06 121.81 28.65 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.581 1.552 . . . . 0.0 110.003 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.6 mt -82.46 139.31 34.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.63 177.8 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 126.825 2.05 . . . . 0.0 106.111 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 pp -131.4 159.66 37.34 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.138 -0.976 . . . . 0.0 111.389 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -167.46 152.63 7.18 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 128.977 2.911 . . . . 0.0 105.025 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -119.97 179.65 4.2 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' H ' HD23 ' A' ' 73' ' ' LEU . 25.4 ptt180 -75.32 -177.43 3.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.242 1.417 . . . . 0.0 109.249 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.41 29.0 1.99 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.071 -0.85 . . . . 0.0 114.292 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.795 0 N-CA-C 107.169 -2.373 . . . . 0.0 107.169 -179.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -132.75 153.48 51.15 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.79 160.0 7.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -102.52 151.58 22.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.346 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.79 104.86 9.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.35 1.86 . . . . 0.0 109.782 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.84 126.11 30.57 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.7 p -87.24 167.07 14.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 118.173 0.442 . . . . 0.0 111.355 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -66.91 -22.99 65.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -79.82 4.07 17.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.239 1.016 . . . . 0.0 110.821 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.18 82.86 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 126.368 1.937 . . . . 0.0 112.494 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -88.08 -177.72 5.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.6 1.96 . . . . 0.0 109.383 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 m -140.6 145.77 37.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -138.03 155.64 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 127.95 2.5 . . . . 0.0 104.7 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 m -124.43 141.59 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -126.57 161.8 27.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -114.76 122.87 47.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.42 179.13 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 125.991 1.716 . . . . 0.0 110.94 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -147.0 160.75 39.32 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.681 1.193 . . . . 0.0 108.162 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.93 -40.13 87.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.563 2.842 . . . . 0.0 113.747 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -78.27 -10.62 59.74 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.237 1.415 . . . . 0.0 112.85 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.45 125.64 29.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 120.553 1.524 . . . . 0.0 108.925 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.0 p -70.71 160.18 33.11 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 -21.53 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.597 0.635 . . . . 0.0 109.712 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.61 -40.32 71.93 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.536 1.534 . . . . 0.0 108.594 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -70.15 -51.26 32.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.506 1.522 . . . . 0.0 109.831 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.5 t -56.55 -39.94 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.683 1.193 . . . . 0.0 109.474 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -68.03 -42.53 80.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.203 1.401 . . . . 0.0 108.705 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.9 96.61 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.62 0.768 . . . . 0.0 109.383 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -62.29 -31.55 72.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.702 2.001 . . . . 0.0 112.649 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -81.09 -40.0 18.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 120.11 1.323 . . . . 0.0 108.16 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -55.43 -41.59 73.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.943 0.792 . . . . 0.0 109.018 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.79 -6.58 1.82 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.646 2.379 . . . . 0.0 113.336 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -135.99 7.14 3.17 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.439 1.895 . . . . 0.0 111.864 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -132.41 -28.79 1.63 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.918 0.887 . . . . 0.0 113.228 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.76 56.0 17.03 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 119.449 1.022 . . . . 0.0 112.964 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.75 172.8 5.66 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.878 1.671 . . . . 0.0 108.175 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.55 171.58 7.26 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.236 2.624 . . . . 0.0 114.262 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -67.57 -0.65 5.44 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 124.566 3.511 . . . . 0.0 112.571 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.28 162.33 17.66 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.805 3.242 . . . . 0.0 108.325 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 61.94 15.45 7.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.961 0.8 . . . . 0.0 112.324 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -160.93 122.22 2.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.841 1.256 . . . . 0.0 109.006 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -145.88 154.81 42.38 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.287 1.435 . . . . 0.0 109.776 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.22 153.48 19.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.821 1.248 . . . . 0.0 111.978 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -139.42 119.93 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.667 1.987 . . . . 0.0 108.889 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -107.74 119.45 39.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 121.122 1.783 . . . . 0.0 108.002 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.04 45.97 15.88 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.443 1.097 . . . . 0.0 110.637 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.07 5.48 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 117.843 -1.532 . . . . 0.0 114.114 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -67.77 132.67 47.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 120.715 2.258 . . . . 0.0 109.168 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.91 131.97 36.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.95 143.55 49.83 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.521 0.728 . . . . 0.0 109.051 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -157.09 167.69 29.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.147 0.979 . . . . 0.0 109.384 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.4 135.78 53.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.94 -14.84 4.07 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.548 2.023 . . . . 0.0 112.032 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -128.64 -178.77 4.72 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.106 1.762 . . . . 0.0 110.687 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.3 p -114.74 166.51 11.67 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 110.837 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -32.53 74.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.137 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -75.59 -37.37 59.92 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.856 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -59.8 -45.72 91.44 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.899 1.227 . . . . 0.0 107.984 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -75.53 -6.0 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.563 0.745 . . . . 0.0 112.072 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 t30 46.23 75.34 0.12 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.726 2.411 . . . . 0.0 110.312 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -115.29 111.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.396 1.478 . . . . 0.0 109.646 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -70.93 166.86 20.31 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -72.45 167.62 20.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.094 0.473 . . . . 0.0 111.09 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.11 30.95 5.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.295 2.238 . . . . 0.0 111.337 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.11 -177.5 3.44 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.058 0.943 . . . . 0.0 108.539 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.2 m -142.8 138.73 30.6 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.86 163.93 23.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 O-C-N 124.488 1.117 . . . . 0.0 110.951 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -119.1 129.41 55.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.925 1.69 . . . . 0.0 109.356 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 69' ' ' LEU . 11.2 mt -85.64 135.93 33.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -144.48 139.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -81.06 145.79 30.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -151.26 147.34 26.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.7 -179.84 8.39 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.71 1.604 . . . . 0.0 107.816 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -66.76 168.61 9.26 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.443 0.697 . . . . 0.0 111.365 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.89 50.21 4.13 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.108 0.48 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -143.4 154.12 43.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 156.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -101.67 147.2 26.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -134.61 118.54 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -86.1 124.16 32.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -86.84 171.63 10.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.161 0.984 . . . . 0.0 111.193 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.2 mt -67.32 -18.65 65.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.719 0.808 . . . . 0.0 110.807 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -83.73 0.33 47.62 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.077 2.151 . . . . 0.0 110.321 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.19 87.17 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.837 1.684 . . . . 0.0 111.564 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -80.34 167.66 19.96 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.523 1.529 . . . . 0.0 108.66 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -135.1 137.35 42.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -128.53 146.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 m -107.66 132.58 53.17 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -121.9 151.3 40.85 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.98 128.35 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.5 -174.43 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.02 1.728 . . . . 0.0 111.76 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -143.2 162.53 42.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.945 1.698 . . . . 0.0 108.877 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.18 -37.42 98.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.944 2.429 . . . . 0.0 114.751 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -79.89 -12.91 59.71 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.834 0.854 . . . . 0.0 112.411 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -59.11 124.9 21.48 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.966 0.803 . . . . 0.0 110.241 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -71.68 158.28 36.44 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -57.6 -20.39 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 122.695 0.398 . . . . 0.0 110.505 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.5 -46.24 87.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.186 1.795 . . . . 0.0 108.034 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -59.52 -47.88 83.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.187 1.395 . . . . 0.0 109.701 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 26' ' ' VAL . 5.3 t -60.74 -46.82 95.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 125.01 1.324 . . . . 0.0 109.369 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.66 -36.77 84.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.986 1.314 . . . . 0.0 109.125 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.92 -44.28 69.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.38 1.072 . . . . 0.0 109.26 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -63.38 -34.11 77.01 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.055 1.342 . . . . 0.0 111.008 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -73.0 -39.8 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.72 1.6 . . . . 0.0 107.104 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.38 -31.23 70.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.361 0.982 . . . . 0.0 110.304 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.43 -12.75 33.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.865 1.666 . . . . 0.0 111.522 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.61 -8.07 2.84 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 125.058 1.343 . . . . 0.0 114.275 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -120.33 -16.93 8.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.945 1.298 . . . . 0.0 112.41 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.88 67.11 0.78 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.666 2.079 . . . . 0.0 114.364 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.69 159.96 69.43 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 124.843 1.257 . . . . 0.0 108.8 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 24.0 Cg_exo -63.38 150.85 87.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.553 1.502 . . . . 0.0 113.997 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 39.4 Cg_exo -65.06 -14.54 45.83 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.936 3.09 . . . . 0.0 112.455 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -96.42 164.38 12.66 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 70.81 -74.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.557 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -61.92 132.8 54.19 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 110.972 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 51.4 ttm-85 -142.64 154.69 44.61 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.916 1.686 . . . . 0.0 113.061 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.73 157.88 15.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.195 1.798 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 mm -140.67 152.68 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 127.395 2.278 . . . . 0.0 106.563 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -140.64 118.32 11.64 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 39.9 8.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.165 0.986 . . . . 0.0 110.415 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.16 -18.4 17.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.894 -1.504 . . . . 0.0 114.325 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.49 132.32 47.38 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 120.689 2.244 . . . . 0.0 107.58 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.16 124.39 28.29 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.4 mt -114.49 151.26 33.54 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.466 0.65 . . . . 0.0 110.427 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -165.29 167.04 18.29 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.852 2.461 . . . . 0.0 105.152 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.45 149.31 50.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 122.53 1.157 . . . . 0.0 112.596 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 136.57 -16.95 3.77 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 127.36 2.41 . . . . 0.0 112.786 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -131.13 -165.98 1.64 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.174 1.79 . . . . 0.0 111.445 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -125.21 174.77 7.86 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.688 1.995 . . . . 0.0 110.17 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.5 -42.21 92.37 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.979 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -38.28 76.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.688 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.88 -43.8 97.81 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 118.648 0.658 . . . . 0.0 109.996 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -74.7 -0.07 16.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.896 0.317 . . . . 0.0 111.42 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.1 t30 50.54 60.09 4.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.404 2.282 . . . . 0.0 109.396 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.1 mt -102.54 106.87 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 126.848 2.059 . . . . 0.0 106.015 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -71.94 151.36 43.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -62.29 163.2 8.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.148 0.975 . . . . 0.0 108.722 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 53.85 33.54 17.34 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.289 1.836 . . . . 0.0 110.31 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.78 -177.76 2.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.995 1.318 . . . . 0.0 109.64 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -137.65 89.57 2.43 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.14 162.46 25.78 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -125.98 161.85 26.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -130.0 125.4 35.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.738 1.615 . . . . 0.0 107.591 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.92 -167.42 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.22 163.16 30.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.032 0.92 . . . . 0.0 109.134 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -148.27 170.79 17.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.044 2.138 . . . . 0.0 106.7 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -166.57 168.3 14.72 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.944 1.298 . . . . 0.0 109.623 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 24.8 ptt180 -74.42 -175.09 2.22 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 109.62 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.16 -11.79 71.19 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.037 -0.868 . . . . 0.0 114.22 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.84 151.78 47.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.162 1.346 . . . . 0.0 109.833 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 163.17 28.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 126.049 1.739 . . . . 0.0 107.816 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.98 157.06 16.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.28 115.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 126.316 1.846 . . . . 0.0 107.421 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -91.74 117.49 29.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -82.89 172.55 12.7 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.074 0.55 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.15 -30.52 69.37 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.229 -0.919 . . . . 0.0 111.281 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -74.0 -1.49 20.13 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.144 0.977 . . . . 0.0 111.781 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.27 9.87 86.07 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.012 1.292 . . . . 0.0 111.131 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -79.95 154.08 28.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 108.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -120.1 137.83 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.462 0.648 . . . . 0.0 109.569 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.8 mt -129.54 156.48 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 127.884 2.474 . . . . 0.0 105.604 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 m -119.91 139.04 53.04 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.2 mt -131.43 151.89 51.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.744 1.218 . . . . 0.0 109.719 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -103.52 135.96 44.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.8 -179.43 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.543 2.737 . . . . 0.0 110.96 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -134.98 159.64 71.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.067 1.747 . . . . 0.0 107.666 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -60.91 -34.46 91.05 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.062 2.508 . . . . 0.0 115.346 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -84.91 -7.91 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.128 0.971 . . . . 0.0 111.603 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -57.54 125.64 23.78 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.73 1.15 . . . . 0.0 112.33 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -72.35 157.73 37.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 59' ' ' TYR . 43.0 mm -55.9 -19.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.007 1.323 . . . . 0.0 112.922 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.65 -49.78 76.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.331 2.653 . . . . 0.0 107.565 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -57.71 -50.64 72.54 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.189 1.796 . . . . 0.0 109.021 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -53.13 -48.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.704 1.601 . . . . 0.0 110.415 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -73.95 -36.63 64.64 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.341 0.973 . . . . 0.0 110.101 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.67 77.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.571 1.078 . . . . 0.0 111.088 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -63.06 -35.41 80.14 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.046 1.339 . . . . 0.0 112.11 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -84.32 -37.26 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.497 1.044 . . . . 0.0 108.227 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -59.95 -31.1 69.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.229 0.922 . . . . 0.0 109.992 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -17.51 58.64 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.692 1.197 . . . . 0.0 110.259 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.28 0.28 11.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.019 2.528 . . . . 0.0 112.256 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -115.92 -30.89 5.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.033 1.333 . . . . 0.0 111.596 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.15 39.33 92.58 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.134 0.873 . . . . 0.0 113.266 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.69 155.92 76.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.76 1.624 . . . . 0.0 107.462 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -88.12 173.57 4.82 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.287 2.658 . . . . 0.0 110.696 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -57.48 -12.79 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.89 3.06 . . . . 0.0 115.547 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.92 145.69 29.26 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.83 30.49 16.64 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.717 -0.614 . . . . 0.0 109.878 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.57 127.36 1.99 Allowed 'General case' 0 C--N 1.339 0.15 0 O-C-N 120.638 -1.289 . . . . 0.0 111.835 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -144.43 144.17 31.26 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.043 0.937 . . . . 0.0 109.503 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -96.21 150.8 20.13 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.322 1.849 . . . . 0.0 108.514 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -134.92 154.94 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 129.725 3.21 . . . . 0.0 103.889 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.94 -46.08 3.14 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 122.673 2.488 . . . . 0.0 114.737 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.54 49.06 0.31 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 127.139 2.175 . . . . 0.0 107.04 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.3 17.33 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.189 1.376 . . . . 0.0 111.103 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -73.96 131.22 41.2 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -78.52 135.46 37.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -116.58 119.14 34.62 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.558 0.743 . . . . 0.0 110.699 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -130.8 172.32 12.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.856 1.263 . . . . 0.0 107.851 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -70.65 171.95 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 112.901 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.14 -19.34 37.8 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.369 1.461 . . . . 0.0 111.684 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -127.37 -167.96 1.82 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.576 1.688 . . . . 0.0 111.177 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -128.5 174.64 9.19 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.951 1.301 . . . . 0.0 112.393 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -41.26 98.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.55 1.54 . . . . 0.0 108.666 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -70.81 -44.89 65.61 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.35 -51.14 65.7 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.557 1.071 . . . . 0.0 109.513 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 23' ' ' ILE . 15.3 m-30 -70.15 -3.3 16.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.498 0.719 . . . . 0.0 112.506 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.09 60.85 2.58 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.835 2.854 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.28 118.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -75.24 163.05 27.91 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -67.41 164.52 18.49 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.201 0.524 . . . . 0.0 109.943 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 46.64 35.37 2.98 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.763 2.025 . . . . 0.0 113.758 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -75.72 -177.57 3.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.85 1.66 . . . . 0.0 108.833 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.7 m -139.07 95.76 3.0 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.9 140.66 38.06 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 124.413 1.071 . . . . 0.0 108.196 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.62 134.8 45.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.965 0.348 . . . . 0.0 110.682 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.14 149.94 21.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.76 176.72 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.606 2.362 . . . . 0.0 106.421 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -135.51 154.73 51.3 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -157.71 165.09 36.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.175 1.39 . . . . 0.0 107.607 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.1 OUTLIER -164.91 163.43 20.96 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.17 0.988 . . . . 0.0 110.526 -179.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.5 ptt-85 -74.73 170.52 15.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.67 45.31 3.49 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.575 -1.125 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.02 149.3 52.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.26 167.17 18.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.163 0.985 . . . . 0.0 108.768 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.03 150.87 23.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 t -141.58 104.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.326 2.25 . . . . 0.0 107.12 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 3.8 tppp? -77.39 140.73 39.97 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -104.27 169.33 8.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.278 0.631 . . . . 0.0 112.493 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.36 -25.52 67.22 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.389 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -79.35 3.11 19.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.272 0.942 . . . . 0.0 110.245 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.75 9.66 85.23 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.375 1.941 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -80.68 171.21 15.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.06 1.344 . . . . 0.0 111.471 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -131.28 125.84 33.86 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.55 159.05 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.421 2.288 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.6 m -120.5 141.95 49.74 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.336 1.454 . . . . 0.0 107.379 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.7 mt -136.3 155.64 49.8 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -106.95 130.31 54.63 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.62 172.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 126.694 1.998 . . . . 0.0 111.379 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -131.53 158.77 74.41 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.566 1.146 . . . . 0.0 108.313 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.05 -42.96 64.01 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.886 3.057 . . . . 0.0 114.153 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -86.23 -6.67 58.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 117.791 -1.1 . . . . 0.0 113.178 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -64.93 129.44 39.71 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -69.79 160.04 32.46 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.7 mm -57.75 -19.2 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 122.588 0.355 . . . . 0.0 111.673 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.07 -43.79 98.08 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 125.694 1.597 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -59.31 -52.93 63.55 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 125.497 1.519 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.15 -38.07 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.382 1.473 . . . . 0.0 109.309 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HG2' HE21 ' A' ' 31' ' ' GLN . 26.6 ttpt -71.03 -44.86 64.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.816 1.247 . . . . 0.0 108.683 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.98 91.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.948 1.299 . . . . 0.0 109.185 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -62.96 -32.58 73.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.299 1.439 . . . . 0.0 112.177 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.83 -39.28 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 27' ' ' LYS . 75.6 mt-30 -60.15 -28.85 68.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.269 1.395 . . . . 0.0 110.032 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.2 -9.95 20.22 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.809 1.644 . . . . 0.0 111.094 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -131.48 -25.72 2.13 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.806 1.642 . . . . 0.0 112.689 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -92.79 -26.63 17.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.163 0.985 . . . . 0.0 111.535 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.04 39.69 70.47 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.68 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.51 162.94 47.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.906 1.283 . . . . 0.0 109.054 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.99 165.86 26.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.597 2.198 . . . . 0.0 113.999 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -61.21 -35.03 87.42 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.634 2.223 . . . . 0.0 109.235 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -78.81 161.49 26.76 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 129.478 3.111 . . . . 0.0 108.164 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 63.11 28.34 16.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.53 156.15 13.53 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.668 -1.27 . . . . 0.0 110.059 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -164.07 138.72 5.79 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.601 1.56 . . . . 0.0 108.377 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.39 145.79 24.22 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.4 mm -135.73 148.18 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.541 1.536 . . . . 0.0 107.372 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -139.13 106.91 5.63 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.791 2.436 . . . . 0.0 104.611 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.71 50.91 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.676 . . . . 0.0 110.246 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.95 -18.42 5.06 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.934 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -74.15 126.85 31.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 119.982 1.891 . . . . 0.0 106.825 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.56 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 1.3 mp0 -79.53 141.82 36.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -130.78 137.27 49.37 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.804 0.842 . . . . 0.0 110.327 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -153.21 176.64 11.71 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.712 1.205 . . . . 0.0 108.866 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.88 163.34 5.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.346 1.458 . . . . 0.0 114.612 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.22 1.6 69.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.674 1.131 . . . . 0.0 112.88 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -136.95 -179.49 5.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.233 2.613 . . . . 0.0 109.98 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -125.57 172.21 9.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.591 1.556 . . . . 0.0 109.82 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.56 88.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.047 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.8 p -72.09 -37.52 69.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.701 1.2 . . . . 0.0 113.514 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -64.18 -33.52 75.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.181 0.9 . . . . 0.0 109.75 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -89.04 -1.06 57.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.737 0.815 . . . . 0.0 112.267 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 46.82 74.11 0.16 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.719 2.408 . . . . 0.0 110.822 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.62 123.02 69.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -90.92 179.91 5.64 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -73.42 162.18 29.59 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.277 -0.889 . . . . 0.0 108.746 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 52.47 30.83 8.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.126 1.37 . . . . 0.0 112.316 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.83 170.58 10.79 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -131.01 88.44 2.61 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.39 160.58 26.62 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 6' ' ' LYS . 1.5 m170 -128.58 153.75 46.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.405 1.482 . . . . 0.0 107.448 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.2 mt -114.01 131.92 56.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.14 173.38 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.52 167.17 22.17 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.853 -1.155 . . . . 0.0 113.79 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -160.12 159.08 31.37 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 131.047 3.739 . . . . 0.0 102.927 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.89 -172.82 2.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.579 0.627 . . . . 0.0 112.079 -176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.14 173.11 2.61 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.273 1.029 . . . . 0.0 109.992 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.59 50.71 4.45 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.395 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 117.69 -1.147 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -129.02 157.04 42.83 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 121.729 2.058 . . . . 0.0 111.763 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 162.78 16.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.231 1.413 . . . . 0.0 107.847 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.62 148.39 23.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.63 104.39 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 125.585 1.554 . . . . 0.0 109.391 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.86 132.29 36.07 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -95.42 167.48 11.3 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.594 0.758 . . . . 0.0 110.363 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.21 -18.51 63.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.466 -0.772 . . . . 0.0 109.255 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -80.61 5.02 16.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.282 1.433 . . . . 0.0 111.057 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.9 15.01 81.63 Favored Glycine 0 C--N 1.341 0.839 0 C-N-CA 126.196 1.855 . . . . 0.0 113.243 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -94.53 170.58 9.37 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.737 1.615 . . . . 0.0 109.355 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -138.01 136.68 37.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -128.68 168.74 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.836 1.654 . . . . 0.0 107.536 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.93 143.28 51.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.231 1.813 . . . . 0.0 107.298 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -140.83 154.07 46.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -99.93 135.21 41.69 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.83 176.97 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 128.085 2.554 . . . . 0.0 107.935 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -142.64 159.51 57.04 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.125 0.97 . . . . 0.0 108.889 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.7 -35.79 97.86 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.471 2.781 . . . . 0.0 115.187 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -90.82 -5.18 55.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.286 1.034 . . . . 0.0 112.377 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.59 132.54 46.38 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 p -74.55 156.18 37.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.45 -22.66 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.024 0.93 . . . . 0.0 110.912 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -57.45 -48.31 79.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.263 1.425 . . . . 0.0 107.357 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -59.66 -51.42 69.86 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.677 1.191 . . . . 0.0 109.266 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -53.78 -44.64 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.132 1.373 . . . . 0.0 109.475 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -69.38 -40.71 77.24 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.71 99.09 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.32 -0.862 . . . . 0.0 110.152 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -61.92 -26.72 68.35 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.629 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -92.0 -32.79 5.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 119.856 1.207 . . . . 0.0 109.177 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.59 -29.16 69.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.405 1.457 . . . . 0.0 109.84 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -63.42 -8.94 10.31 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.406 2.682 . . . . 0.0 111.69 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -133.25 -38.93 0.94 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.389 1.476 . . . . 0.0 112.6 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.31 -31.56 43.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.822 0.737 . . . . 0.0 112.507 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.0 58.71 9.16 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.238 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.39 152.79 39.5 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.287 1.435 . . . . 0.0 107.94 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 171.81 11.69 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.954 1.769 . . . . 0.0 111.373 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.26 -21.58 67.13 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.123 2.549 . . . . 0.0 112.46 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -84.45 166.6 17.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.426 1.09 . . . . 0.0 108.745 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 59.39 23.66 12.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.371 0.669 . . . . 0.0 110.966 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.59 146.2 19.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.979 0.912 . . . . 0.0 110.232 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -154.25 165.1 37.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.572 1.949 . . . . 0.0 108.03 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.13 160.04 22.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.608 1.163 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mm -138.74 145.22 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 127.667 2.387 . . . . 0.0 105.384 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -139.36 104.95 5.1 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 60.1 3.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.651 1.581 . . . . 0.0 109.949 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.26 -6.43 7.59 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.175 -1.347 . . . . 0.0 115.969 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -92.85 129.13 38.87 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 120.832 2.316 . . . . 0.0 107.915 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.4 mp0 -78.94 142.53 36.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 mt -118.64 149.08 42.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -150.26 163.93 37.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -70.4 166.51 20.18 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.59 0.756 . . . . 0.0 110.364 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.1 2.76 48.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.297 1.903 . . . . 0.0 110.541 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -136.8 -177.76 4.88 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.761 2.024 . . . . 0.0 111.584 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -116.92 -179.94 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 126.724 2.01 . . . . 0.0 108.59 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -32.92 63.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.71 -37.29 70.66 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.25 0.62 . . . . 0.0 110.653 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -56.19 -42.3 76.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.811 0.732 . . . . 0.0 109.105 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.19 0.02 42.95 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 t30 46.5 67.05 0.83 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.086 2.154 . . . . 0.0 109.445 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -103.82 109.94 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 126.821 2.048 . . . . 0.0 108.011 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -70.93 164.46 25.38 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.754 0.821 . . . . 0.0 108.892 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -70.91 158.04 37.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 57.09 33.64 23.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.993 1.317 . . . . 0.0 112.23 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.48 173.02 9.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -134.65 96.73 3.62 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.46 155.53 21.2 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.469 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.74 123.26 43.32 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.714 1.206 . . . . 0.0 109.869 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.59 130.51 35.16 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -143.28 152.57 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.28 132.65 56.08 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -149.68 125.29 10.36 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.76 175.57 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 19.2 ptt180 -68.2 172.25 6.04 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.175 1.79 . . . . 0.0 109.112 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.77 -3.27 49.44 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 117.738 -1.59 . . . . 0.0 116.799 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.464 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -107.92 140.28 41.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.794 1.179 . . . . 0.0 109.91 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.8 156.55 40.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.193 0.997 . . . . 0.0 108.453 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.52 149.11 23.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -134.47 104.04 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 126.25 1.82 . . . . 0.0 106.571 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -79.11 138.89 38.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -99.19 164.13 12.27 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.663 1.185 . . . . 0.0 111.136 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 mt -69.34 -22.81 63.73 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.9 p -76.44 5.01 7.89 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.715 1.606 . . . . 0.0 111.177 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.18 28.42 68.26 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 125.923 1.725 . . . . 0.0 112.283 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -113.38 178.11 4.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.319 1.848 . . . . 0.0 109.655 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.53 143.87 34.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -131.37 162.53 39.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.37 149.26 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -135.62 177.05 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.393 1.077 . . . . 0.0 109.29 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -125.72 125.25 42.7 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.46 -177.03 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.75 2.42 . . . . 0.0 106.956 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -149.39 161.44 31.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 -32.23 65.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.085 3.19 . . . . 0.0 113.797 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.9 t -79.65 -17.58 53.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.581 1.552 . . . . 0.0 113.153 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.78 136.78 51.29 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.1 p -79.16 159.28 27.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -58.29 -22.3 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.565 0.746 . . . . 0.0 111.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -55.54 -49.12 73.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.568 1.547 . . . . 0.0 106.899 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -59.82 -54.16 49.47 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.621 1.568 . . . . 0.0 109.695 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -53.33 -44.58 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.593 1.157 . . . . 0.0 109.707 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -68.75 -44.88 72.84 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.491 1.117 . . . . 0.0 109.926 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.6 92.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.707 0.803 . . . . 0.0 110.449 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -59.32 -28.53 66.89 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.713 1.605 . . . . 0.0 111.995 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 tp -92.39 -33.72 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 119.07 0.85 . . . . 0.0 108.716 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -57.56 -35.06 69.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.013 1.279 . . . . 0.0 109.008 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.11 -11.53 9.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.852 2.861 . . . . 0.0 112.736 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -126.38 -39.28 2.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 125.144 1.378 . . . . 0.0 111.472 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.11 -38.37 63.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.363 0.529 . . . . 0.0 109.914 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 55.02 9.08 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.52 -0.6 . . . . 0.0 111.821 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.65 156.05 71.3 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.602 1.161 . . . . 0.0 108.267 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.56 168.17 24.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 121.885 1.723 . . . . 0.0 110.459 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.74 -37.03 89.7 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.98 2.453 . . . . 0.0 112.517 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.12 164.07 26.34 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.219 1.008 . . . . 0.0 110.138 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 61.69 24.5 14.6 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 111.385 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -153.55 153.18 31.91 Favored 'General case' 0 C--N 1.343 0.298 0 O-C-N 120.729 -1.232 . . . . 0.0 113.468 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -158.85 168.64 26.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.53 1.932 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -122.92 160.41 26.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.972 1.309 . . . . 0.0 109.053 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mm -138.63 144.76 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 127.198 2.199 . . . . 0.0 105.781 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -138.32 103.43 4.91 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 128.216 2.606 . . . . 0.0 104.038 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.1 60.33 3.66 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.656 1.582 . . . . 0.0 110.271 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.41 -5.76 14.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 117.768 -1.574 . . . . 0.0 116.336 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -95.87 129.8 43.01 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 120.599 2.2 . . . . 0.0 107.429 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.525 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.3 mp0 -78.89 135.34 36.97 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.56 125.97 54.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.91 159.09 42.74 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.107 1.763 . . . . 0.0 107.227 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.66 169.49 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.79 1.16 39.63 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.118 1.818 . . . . 0.0 110.306 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -137.46 -177.38 4.76 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.379 1.872 . . . . 0.0 111.432 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.0 p -116.81 170.28 8.73 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.549 1.94 . . . . 0.0 107.913 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -29.13 69.47 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -69.69 -40.52 76.29 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.536 1.134 . . . . 0.0 110.397 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.41 -41.76 97.67 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.463 0.705 . . . . 0.0 110.968 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -79.54 -3.49 47.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 122.012 -0.43 . . . . 0.0 111.241 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.0 t30 47.29 65.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.275 2.23 . . . . 0.0 110.004 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mt -99.47 120.83 49.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.762 1.625 . . . . 0.0 108.389 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -77.97 162.1 27.02 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.143 0.977 . . . . 0.0 109.712 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -65.18 161.39 19.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.116 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 45.66 47.65 11.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.755 1.622 . . . . 0.0 112.235 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.49 173.66 12.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.0 m -140.26 94.27 2.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.53 163.16 23.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.474 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -125.11 119.49 28.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.751 1.62 . . . . 0.0 108.762 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.78 133.2 36.3 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.73 172.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.11 129.4 31.77 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.81 131.13 15.59 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.899 1.679 . . . . 0.0 107.963 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mt -132.26 -179.98 5.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.374 0.67 . . . . 0.0 112.649 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 76' ' ' GLY . 30.1 ptt180 -68.81 171.65 7.6 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.582 1.553 . . . . 0.0 108.86 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.02 8.37 57.52 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 117.084 1.594 . . . . 0.0 117.084 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.75 153.29 49.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.73 170.54 9.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.995 1.318 . . . . 0.0 107.678 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.42 154.68 24.3 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.5 t -138.5 122.62 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.221 1.009 . . . . 0.0 109.165 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -88.69 123.43 33.13 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 p -84.63 166.64 16.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.344 0.658 . . . . 0.0 110.822 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.3 -26.59 68.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.9 p -73.08 -4.3 31.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.462 0.574 . . . . 0.0 110.742 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 9.38 72.1 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.71 1.624 . . . . 0.0 113.28 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -89.72 172.93 8.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.358 1.463 . . . . 0.0 110.26 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -127.39 141.1 51.77 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -132.63 152.74 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 106.085 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -111.92 145.55 39.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 mt -139.17 158.99 43.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -118.27 132.22 56.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.52 178.32 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.405 2.282 . . . . 0.0 110.858 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.22 164.6 40.8 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.416 1.486 . . . . 0.0 109.041 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.65 -34.49 92.12 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.819 3.012 . . . . 0.0 114.081 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t -83.52 -11.25 57.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.067 0.947 . . . . 0.0 111.326 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -64.1 116.89 6.36 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.623 1.101 . . . . 0.0 110.775 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -70.59 155.33 40.87 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -57.13 -24.68 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.01 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -59.09 -38.9 80.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -67.52 -48.0 68.29 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.543 0.737 . . . . 0.0 110.018 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 t -57.29 -44.46 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 124.164 0.986 . . . . 0.0 108.649 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -64.5 -42.1 96.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.153 1.381 . . . . 0.0 108.211 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 97.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.995 0.816 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -61.85 -30.15 70.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.124 1.77 . . . . 0.0 112.226 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.09 -36.06 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -58.98 -37.77 77.59 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.86 -9.72 1.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.041 2.537 . . . . 0.0 112.472 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -135.24 8.92 3.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.594 1.958 . . . . 0.0 111.436 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -133.9 -26.4 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.901 1.228 . . . . 0.0 113.533 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.88 -24.7 1.89 Allowed Glycine 0 CA--C 1.534 1.226 0 O-C-N 120.471 -1.393 . . . . 0.0 115.919 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 41' ' ' ASN . 2.9 pp -57.95 154.95 26.02 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-N 120.269 2.035 . . . . 0.0 112.084 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.04 168.44 24.77 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.59 2.194 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.14 -6.58 10.01 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 122.958 2.439 . . . . 0.0 115.378 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -107.8 166.7 10.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 108.639 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 56.93 36.35 27.64 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.69 -1.256 . . . . 0.0 110.988 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -173.89 132.83 0.43 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.722 1.609 . . . . 0.0 109.322 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -152.91 143.52 22.72 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.223 1.374 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.0 153.97 21.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mm -138.45 140.52 39.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 106.933 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -130.47 109.43 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.41 36.51 5.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.55 1.94 . . . . 0.0 113.137 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.51 -9.96 62.79 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -91.77 126.77 36.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 120.317 2.058 . . . . 0.0 106.398 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.3 132.9 36.6 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.9 mt -108.22 132.32 53.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.455 0.702 . . . . 0.0 110.069 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.87 -179.62 6.72 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.94 1.296 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.82 168.92 1.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.977 2.111 . . . . 0.0 112.079 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.21 -2.88 64.15 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.986 -0.896 . . . . 0.0 113.659 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -125.05 172.53 9.37 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.54 1.536 . . . . 0.0 111.317 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.6 p -130.13 173.53 10.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.83 2.052 . . . . 0.0 108.407 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -34.31 77.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.476 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.12 -39.68 65.56 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 117.57 -1.205 . . . . 0.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 55' ' ' THR . 70.2 m-20 -57.32 -48.83 77.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.933 1.242 . . . . 0.0 109.255 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -77.29 -8.01 56.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.84 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 t30 49.08 64.27 1.8 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 109.758 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -106.27 126.88 61.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.11 171.78 13.37 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.826 0.851 . . . . 0.0 109.853 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -70.16 169.12 14.24 Favored 'General case' 0 CA--C 1.528 0.102 0 O-C-N 121.658 -0.652 . . . . 0.0 109.611 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 47.77 31.21 2.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.89 2.476 . . . . 0.0 113.733 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 176.56 5.34 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -140.39 89.54 2.29 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.26 154.56 29.07 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.147 -1.842 . . . . 0.0 109.07 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -114.26 158.32 21.55 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.118 0.967 . . . . 0.0 108.493 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -117.42 126.21 52.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.861 1.264 . . . . 0.0 108.847 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.08 136.22 44.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 107.828 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.47 158.35 22.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -169.11 109.53 0.47 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.118 2.967 . . . . 0.0 105.696 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -76.72 174.0 10.97 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 127.236 2.214 . . . . 0.0 112.29 -179.173 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.442 ' H ' HD23 ' A' ' 73' ' ' LEU . 13.0 ptt180 -66.4 -176.34 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.98 1.312 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.12 -3.06 55.46 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.919 0 CA-C-N 120.119 1.96 . . . . 0.0 108.762 -179.811 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -132.89 154.86 49.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.79 157.61 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -98.35 148.54 23.56 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.239 1.416 . . . . 0.0 108.446 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.6 t -133.1 117.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -89.77 123.81 34.09 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -82.4 161.81 22.37 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.411 0.551 . . . . 0.0 109.749 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.25 -29.38 69.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.224 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.5 p -71.87 -6.52 42.33 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.806 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.21 23.5 31.84 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 125.26 1.41 . . . . 0.0 112.115 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -99.35 168.44 10.01 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.827 1.314 . . . . 0.0 108.757 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -130.08 138.67 50.84 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.56 149.96 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 126.446 1.899 . . . . 0.0 106.018 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.5 m -120.21 139.42 52.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.3 mt -123.67 -179.93 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.062 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.93 129.02 48.45 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -144.15 166.94 12.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 124.96 1.304 . . . . 0.0 110.618 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -131.21 160.94 64.76 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 126.973 2.109 . . . . 0.0 107.127 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.27 -24.55 72.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 121.893 1.729 . . . . 0.0 111.124 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -83.76 -11.01 57.69 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.205 1.002 . . . . 0.0 110.177 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.85 124.75 24.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.8 t -90.31 167.12 12.9 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.757 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.99 -25.53 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -62.28 -42.28 99.21 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -75.39 -46.91 30.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.427 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.37 -47.35 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.939 0.896 . . . . 0.0 112.196 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -62.48 -34.27 76.52 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.414 1.007 . . . . 0.0 110.323 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.04 70.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -56.96 -43.17 81.34 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.11 1.364 . . . . 0.0 111.448 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tp -76.25 -39.04 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.823 1.192 . . . . 0.0 110.773 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.15 -33.24 71.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.983 1.265 . . . . 0.0 109.449 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -64.52 -11.72 37.07 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.312 1.445 . . . . 0.0 111.975 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -126.92 10.34 7.0 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.79 1.636 . . . . 0.0 112.841 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -130.66 -34.08 1.57 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.214 1.006 . . . . 0.0 110.6 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.35 42.54 96.01 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 125.143 1.354 . . . . 0.0 114.174 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.75 166.31 29.2 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.759 1.279 . . . . 0.0 110.583 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.79 161.9 42.58 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.009 2.473 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.49 -36.58 88.69 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.761 2.307 . . . . 0.0 112.46 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.31 160.68 28.66 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.701 0.8 . . . . 0.0 109.786 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 69.98 22.52 5.76 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.66 1.584 . . . . 0.0 110.309 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.58 157.81 43.79 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.174 1.39 . . . . 0.0 108.188 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -167.13 133.52 2.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.093 0.957 . . . . 0.0 108.687 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -97.74 123.34 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm -115.28 103.81 15.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 109.762 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -93.67 107.81 19.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.16 44.19 19.13 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.41 52.26 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.826 1.203 . . . . 0.0 114.029 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -68.79 122.58 18.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 120.414 2.107 . . . . 0.0 108.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.77 93.84 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.8 mt -73.53 145.2 45.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.09 -0.381 . . . . 0.0 110.321 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -155.42 163.53 39.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.151 2.18 . . . . 0.0 108.811 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -69.33 166.94 17.5 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.38 4.67 52.96 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.117 1.341 . . . . 0.0 110.607 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -139.5 177.66 7.77 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.95 1.7 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.1 p -124.08 168.92 12.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.987 2.515 . . . . 0.0 107.921 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -34.18 73.87 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.813 -0.554 . . . . 0.0 109.63 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -58.93 -52.31 66.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.266 0.626 . . . . 0.0 109.644 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.59 -32.16 71.28 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.08 1.352 . . . . 0.0 111.692 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.42 -10.81 55.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.657 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.5 t30 49.92 74.74 0.19 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.947 1.356 . . . . 0.0 108.954 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.7 121.57 66.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -88.43 166.92 13.9 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.735 0.814 . . . . 0.0 108.894 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -65.44 158.35 26.98 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 47.65 45.36 17.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.166 2.186 . . . . 0.0 111.977 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 p -88.08 172.43 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.892 1.677 . . . . 0.0 106.732 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -130.37 109.93 11.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.55 109.08 21.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.91 139.25 37.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.072 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.79 128.29 44.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.85 0.75 . . . . 0.0 110.552 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.27 153.01 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -79.59 161.34 25.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.956 1.36 . . . . 0.0 114.012 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -149.84 123.32 9.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 126.815 2.046 . . . . 0.0 106.358 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.94 175.76 9.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.453 1.501 . . . . 0.0 108.062 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -82.69 165.16 20.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.22 50.58 4.4 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 116.618 -2.212 . . . . 0.0 110.516 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -93.69 151.45 19.64 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.24 159.03 15.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -104.19 152.97 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -140.15 120.36 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.36 1.064 . . . . 0.0 108.581 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -87.52 124.51 33.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -84.46 173.28 10.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.669 1.188 . . . . 0.0 112.129 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.5 mt -66.33 -25.69 66.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.265 0.626 . . . . 0.0 109.534 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.1 p -81.16 3.64 22.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.729 1.212 . . . . 0.0 110.868 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.27 13.35 82.88 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 125.43 1.491 . . . . 0.0 112.054 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -85.92 169.46 13.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.277 1.831 . . . . 0.0 109.638 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -128.58 136.26 50.48 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.6 mt -130.14 150.71 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -116.34 145.63 43.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -138.75 168.01 20.74 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -121.8 125.35 46.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.32 178.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 127.966 2.506 . . . . 0.0 108.763 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -137.73 157.62 73.16 Favored Pre-proline 0 C--O 1.234 0.256 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.91 -40.82 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.379 2.719 . . . . 0.0 113.758 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -75.5 -12.96 60.34 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.99 147.83 40.45 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 119.756 1.162 . . . . 0.0 111.058 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 46.0 p -83.86 161.91 20.72 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.45 -15.69 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 110.349 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -58.3 -53.92 52.86 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -53.3 -51.59 61.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.386 1.875 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.9 -49.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 125.333 1.453 . . . . 0.0 109.808 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -69.13 -33.34 73.3 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.714 0.688 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.18 93.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.192 0.905 . . . . 0.0 110.527 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -67.07 -34.8 78.44 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 111.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -81.01 -34.35 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.243 0.929 . . . . 0.0 108.965 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -56.58 -35.57 68.36 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.672 1.124 . . . . 0.0 109.544 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.65 -16.31 25.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.833 1.253 . . . . 0.0 112.426 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -120.28 -15.55 8.61 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.1 1.76 . . . . 0.0 113.311 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.31 -29.0 11.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.879 0.872 . . . . 0.0 111.173 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.73 40.02 97.5 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.489 1.042 . . . . 0.0 114.408 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.6 pp -128.4 161.85 54.29 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.626 1.57 . . . . 0.0 108.616 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.7 167.7 26.46 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.006 1.137 . . . . 0.0 111.627 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 -16.28 54.15 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.708 2.939 . . . . 0.0 112.927 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -93.72 169.48 10.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 58.82 15.82 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.641 1.564 . . . . 0.0 111.067 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.33 129.75 7.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.157 -1.589 . . . . 0.0 108.822 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -148.6 145.0 27.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.68 153.68 19.51 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.925 1.29 . . . . 0.0 110.453 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.02 155.04 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.179 2.192 . . . . 0.0 107.027 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.07 105.95 4.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.35 54.57 10.9 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.583 1.553 . . . . 0.0 109.131 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.94 -21.04 2.22 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.092 1.329 . . . . 0.0 114.152 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -70.35 127.88 34.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 120.679 2.239 . . . . 0.0 108.0 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.18 139.24 38.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.1 mt -126.23 142.39 51.54 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.933 0.893 . . . . 0.0 109.341 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.57 166.88 31.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.636 0.774 . . . . 0.0 109.737 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.88 135.26 53.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.116 0.966 . . . . 0.0 109.749 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 138.16 -13.82 3.54 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.936 1.731 . . . . 0.0 111.714 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -137.35 -179.99 6.06 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.718 1.607 . . . . 0.0 109.847 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -108.9 167.97 9.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.408 1.083 . . . . 0.0 111.975 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 -34.3 76.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.477 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -33.25 58.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.713 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -61.7 -44.38 97.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.935 1.243 . . . . 0.0 107.657 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -76.5 -5.08 45.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.627 0.771 . . . . 0.0 111.122 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 45.6 75.61 0.11 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 129.418 3.087 . . . . 0.0 111.741 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.46 137.63 47.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -103.1 171.71 7.23 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.885 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -62.84 161.23 13.04 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 45.42 39.07 4.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.824 2.05 . . . . 0.0 112.939 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.68 171.99 13.39 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 m -131.15 93.44 3.38 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.46 161.33 26.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 113.921 -1.491 . . . . 0.0 107.331 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -121.84 160.04 25.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.7 122.73 35.73 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.822 1.249 . . . . 0.0 108.663 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.72 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 pp -121.6 162.67 20.24 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.481 -0.762 . . . . 0.0 109.642 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.15 124.07 28.36 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 101.568 -3.493 . . . . 0.0 101.568 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -134.25 155.28 50.45 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 118.583 0.629 . . . . 0.0 111.315 -178.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' H ' HD13 ' A' ' 73' ' ' LEU . 18.3 ptt180 -75.51 -172.32 1.78 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.988 1.715 . . . . 0.0 110.208 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.69 8.77 0.75 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 116.669 1.428 . . . . 0.0 116.669 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.635 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 179.517 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtp . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.89 157.05 43.14 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.637 -1.289 . . . . 0.0 111.609 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.15 166.5 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 126.627 1.971 . . . . 0.0 106.197 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.44 155.65 21.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.5 111.99 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -80.84 116.3 20.76 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -79.93 168.74 18.84 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.417 0.687 . . . . 0.0 111.29 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -68.53 -24.92 64.7 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.81 4.76 7.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.32 1.048 . . . . 0.0 112.617 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.83 70.24 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.374 1.464 . . . . 0.0 111.315 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -107.11 171.05 7.59 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 108.534 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -137.77 144.69 41.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 mt -139.32 156.56 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.747 1.619 . . . . 0.0 107.454 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -109.44 141.36 41.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.5 mt -127.9 145.72 50.86 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -93.55 126.69 38.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.26 173.59 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 125.203 1.401 . . . . 0.0 109.323 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -135.69 162.07 59.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 121.472 -0.767 . . . . 0.0 110.477 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.27 -38.14 95.58 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.91 2.406 . . . . 0.0 113.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -83.13 -10.85 58.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -59.89 134.56 57.15 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.799 1.181 . . . . 0.0 109.795 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.6 p -83.95 168.94 15.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.8 -25.36 38.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.301 -0.874 . . . . 0.0 108.873 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.57 -38.42 90.95 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.134 0.879 . . . . 0.0 110.149 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.47 -43.19 91.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.7 -45.81 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.591 0.756 . . . . 0.0 109.587 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -62.68 -34.78 77.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.463 1.105 . . . . 0.0 108.591 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.84 56.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.416 1.087 . . . . 0.0 108.827 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.0 -32.17 69.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.434 1.494 . . . . 0.0 111.639 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.52 -38.99 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 119.866 1.212 . . . . 0.0 109.118 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -61.43 -29.22 69.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.609 1.095 . . . . 0.0 109.075 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.67 -1.55 5.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.932 1.293 . . . . 0.0 111.431 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -135.58 4.41 3.1 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.881 2.472 . . . . 0.0 111.843 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.08 -22.11 2.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.346 1.058 . . . . 0.0 112.43 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.04 -28.24 0.3 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 128.767 3.08 . . . . 0.0 116.591 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.33 156.15 16.28 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.963 0.905 . . . . 0.0 113.25 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -66.57 164.78 27.51 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.224 1.949 . . . . 0.0 112.031 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.69 -21.84 73.03 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.988 3.125 . . . . 0.0 113.869 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -77.12 161.52 28.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.565 1.546 . . . . 0.0 108.04 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 58.48 22.51 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.29 1.404 . . . . 0.0 112.551 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.18 162.67 36.54 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 120.863 -1.148 . . . . 0.0 109.229 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -162.63 173.01 14.48 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.266 0.939 . . . . 0.0 110.539 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 129.98 51.41 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' LEU . 13.5 mm -137.16 118.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.056 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -104.6 108.89 20.57 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.146 1.339 . . . . 0.0 107.89 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.85 54.11 9.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.058 1.343 . . . . 0.0 110.081 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.13 -22.47 3.63 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.137 1.351 . . . . 0.0 114.602 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -67.16 124.83 24.19 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 120.708 2.254 . . . . 0.0 108.431 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -79.1 126.52 30.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -112.04 143.1 43.62 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -145.92 163.23 35.77 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.859 0.864 . . . . 0.0 109.26 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.71 127.6 33.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.394 0.616 . . . . 0.0 111.192 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.34 -16.33 1.88 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.891 2.186 . . . . 0.0 110.976 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.51 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 25.1 mmt180 -121.29 177.43 5.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.826 1.251 . . . . 0.0 111.498 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.2 p -116.09 172.28 7.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.277 1.831 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -64.1 -40.04 95.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.357 178.012 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.0 -39.99 68.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.626 -1.178 . . . . 0.0 109.981 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.22 -50.64 70.7 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.25 1.386 . . . . 0.0 109.832 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 39.8 m-85 -72.8 -3.86 27.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t30 51.62 49.29 21.19 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.744 1.618 . . . . 0.0 109.423 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' HB ' HD23 ' A' ' 56' ' ' LEU . 85.3 mt -81.9 108.8 15.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.15 147.71 34.17 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -64.29 161.72 16.14 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 55.94 27.54 11.29 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.981 1.312 . . . . 0.0 112.508 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -75.57 175.38 8.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.9 m -131.09 130.24 42.92 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 6.7 mp -112.78 145.55 40.37 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -108.61 129.05 55.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.451 0.7 . . . . 0.0 111.047 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.75 129.21 34.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.4 152.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.97 161.29 26.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.481 1.134 . . . . 0.0 111.192 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 94.93 2.68 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -104.19 152.72 21.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' H ' HD13 ' A' ' 73' ' ' LEU . 30.7 ptt180 -75.02 -179.54 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.037 0.446 . . . . 0.0 110.876 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.04 26.25 0.8 Allowed Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.36 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.842 0 CA-C-N 120.648 2.224 . . . . 0.0 110.946 179.633 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.84 163.51 29.65 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.103 -0.998 . . . . 0.0 109.379 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.16 160.85 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.566 1.946 . . . . 0.0 106.427 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.03 147.37 28.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 t -135.83 116.03 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.148 0.979 . . . . 0.0 108.921 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.71 136.76 36.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -99.35 165.84 11.48 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.298 1.039 . . . . 0.0 111.416 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.98 -21.21 65.08 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -75.95 -4.53 41.6 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.006 0.522 . . . . 0.0 110.433 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.21 32.46 31.63 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -118.01 176.22 5.31 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 125.824 1.65 . . . . 0.0 108.638 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -134.15 140.07 46.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 71.8 mt -126.11 149.84 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -111.18 141.91 44.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -133.24 157.78 44.55 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -110.6 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.389 1.075 . . . . 0.0 108.505 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.5 m -147.17 176.48 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.551 1.54 . . . . 0.0 110.999 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -134.86 159.14 73.24 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 -36.64 99.11 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.134 3.223 . . . . 0.0 114.655 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -81.67 -13.08 58.33 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.949 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.28 134.55 51.83 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.772 1.169 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 18.2 p -74.51 157.12 36.09 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.18 -18.86 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.787 0.435 . . . . 0.0 110.087 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.46 -49.32 76.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.457 1.903 . . . . 0.0 107.66 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -59.09 -47.81 83.88 Favored 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 125.432 1.493 . . . . 0.0 109.799 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 3.2 t -60.57 -45.44 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.74 1.616 . . . . 0.0 109.025 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.8 -37.4 86.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.116 1.366 . . . . 0.0 108.542 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.01 77.95 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.048 0.939 . . . . 0.0 109.88 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.2 -32.53 74.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.919 1.288 . . . . 0.0 111.534 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tp -77.64 -43.62 29.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -56.07 -35.69 67.26 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.796 0.725 . . . . 0.0 109.691 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.65 -15.63 12.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.098 1.359 . . . . 0.0 112.966 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -128.62 5.46 5.6 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.539 1.936 . . . . 0.0 111.622 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -122.85 -31.26 3.7 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.869 1.268 . . . . 0.0 111.552 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.6 -15.4 3.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.623 2.059 . . . . 0.0 114.988 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.32 153.09 95.42 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.371 1.586 . . . . 0.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.43 169.41 21.78 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.975 2.45 . . . . 0.0 109.326 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -55.97 -18.22 21.76 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.096 2.53 . . . . 0.0 116.407 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.5 170.73 9.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.2 1.4 . . . . 0.0 110.647 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 60.82 30.49 19.7 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.957 -1.089 . . . . 0.0 109.952 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.54 155.35 19.6 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.372 -0.83 . . . . 0.0 111.512 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -161.21 129.76 4.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.754 1.222 . . . . 0.0 112.044 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.91 145.63 32.57 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -137.92 154.52 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.216 1.806 . . . . 0.0 107.642 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -147.53 111.43 5.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.335 2.254 . . . . 0.0 105.051 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.16 43.45 31.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.857 0.863 . . . . 0.0 109.605 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.84 -17.02 4.83 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.684 -1.064 . . . . 0.0 112.897 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -67.24 127.84 34.14 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.796 1.798 . . . . 0.0 107.406 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.1 mp0 -79.55 133.85 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.44 145.35 49.55 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.299 1.04 . . . . 0.0 109.725 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -153.25 174.5 14.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -66.42 170.96 5.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.733 0.778 . . . . 0.0 111.028 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.02 -11.97 58.89 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.024 -1.431 . . . . 0.0 114.287 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.29 -179.01 5.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.691 1.746 . . . . 0.0 111.375 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 79.4 p -113.02 172.55 6.87 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.837 1.255 . . . . 0.0 114.02 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -35.96 79.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.062 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 t -69.63 -41.47 75.6 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.61 -44.1 96.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.969 0.804 . . . . 0.0 110.903 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -79.36 -2.65 42.61 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.631 -0.668 . . . . 0.0 112.052 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.4 t30 46.86 65.02 1.33 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.096 2.158 . . . . 0.0 110.285 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.24 111.92 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 126.157 1.783 . . . . 0.0 106.634 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.7 160.22 31.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -60.3 165.14 3.73 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.005 0.922 . . . . 0.0 110.736 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 47.82 40.86 13.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.543 1.537 . . . . 0.0 112.498 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.3 171.2 15.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.034 1.734 . . . . 0.0 107.53 178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -128.78 87.14 2.53 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.73 153.8 29.0 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.674 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -122.3 159.12 28.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 108.347 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.44 126.73 48.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.46 -178.99 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 127.823 2.449 . . . . 0.0 104.441 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 pp -137.52 174.22 10.83 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.798 1.285 . . . . 0.0 113.117 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt-85 -154.35 160.62 41.8 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.748 4.019 . . . . 0.0 102.294 176.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 74' ' ' ARG . 0.6 OUTLIER -135.73 171.18 14.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 120.205 1.366 . . . . 0.0 111.666 -177.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 73' ' ' LEU . 4.3 ptt180 -71.61 -178.55 2.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 109.69 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.55 11.16 5.76 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.249 -1.306 . . . . 0.0 115.036 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-N 120.198 1.999 . . . . 0.0 108.657 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -131.77 154.39 49.12 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.62 158.22 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -97.67 146.34 25.42 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -132.63 104.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 125.341 1.456 . . . . 0.0 108.637 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -79.2 132.43 36.52 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.2 p -94.59 166.84 11.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.223 1.409 . . . . 0.0 112.52 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.64 -27.24 69.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.358 0.663 . . . . 0.0 110.038 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -75.7 -2.62 30.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.737 2.015 . . . . 0.0 111.842 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.07 36.88 44.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.505 1.05 . . . . 0.0 110.827 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -115.22 173.09 6.68 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.225 1.81 . . . . 0.0 107.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -134.93 136.64 42.45 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.4 mt -123.23 161.05 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.608 2.363 . . . . 0.0 105.059 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.7 m -126.33 140.08 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -128.37 154.18 46.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -104.61 124.35 49.17 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.84 170.07 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.399 1.479 . . . . 0.0 110.85 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -131.52 158.64 74.76 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.04 -36.72 99.39 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.811 3.007 . . . . 0.0 113.946 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -77.6 -11.87 59.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.665 1.186 . . . . 0.0 111.693 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -74.09 142.51 45.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.224 1.374 . . . . 0.0 111.138 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -86.75 161.26 18.49 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.795 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -55.69 -25.07 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 122.954 0.502 . . . . 0.0 110.737 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -51.89 -50.37 61.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.416 1.886 . . . . 0.0 108.291 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -61.76 -51.08 69.8 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 125.254 1.422 . . . . 0.0 111.187 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 26' ' ' VAL . 15.7 t -56.77 -46.23 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 126.247 1.819 . . . . 0.0 109.516 -178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -67.33 -37.55 83.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.887 1.675 . . . . 0.0 109.134 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.68 73.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.54 0.736 . . . . 0.0 109.947 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -61.22 -33.24 73.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.869 1.668 . . . . 0.0 112.288 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.44 -39.06 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 119.761 1.164 . . . . 0.0 109.461 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -58.37 -35.28 71.74 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.474 1.034 . . . . 0.0 109.088 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.31 -4.25 7.55 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.353 1.861 . . . . 0.0 112.808 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -137.79 8.31 2.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.789 2.036 . . . . 0.0 112.456 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -133.55 -33.63 1.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.543 1.137 . . . . 0.0 110.76 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.77 61.04 6.55 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.323 1.439 . . . . 0.0 114.893 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.44 162.49 44.53 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 108.823 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.49 162.33 30.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.99 1.793 . . . . 0.0 110.264 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.23 -27.19 72.25 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.046 1.831 . . . . 0.0 110.962 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.34 142.54 32.96 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.914 1.686 . . . . 0.0 106.505 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 70.89 33.89 2.06 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -161.15 143.17 12.12 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.959 -1.088 . . . . 0.0 110.41 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -161.12 153.14 19.82 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.898 1.279 . . . . 0.0 108.764 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.74 140.89 47.9 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.9 mm -132.61 115.63 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.069 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -98.74 108.15 20.76 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.35 53.05 12.52 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 111.122 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.53 -13.32 12.0 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.971 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -78.47 122.83 26.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 120.037 1.919 . . . . 0.0 109.086 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.4 mp0 -79.42 133.15 36.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.0 139.8 53.7 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.887 0.875 . . . . 0.0 109.745 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -150.2 168.39 24.13 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.685 1.194 . . . . 0.0 109.906 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.54 156.03 20.62 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.785 0.802 . . . . 0.0 111.646 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.78 -5.51 34.82 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.984 1.278 . . . . 0.0 111.227 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -129.07 -179.78 5.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.419 1.609 . . . . 0.0 110.657 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.3 p -127.27 165.84 18.91 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 126.454 1.902 . . . . 0.0 110.574 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -34.82 72.34 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 122.917 0.487 . . . . 0.0 110.573 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -37.41 69.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.121 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -59.14 -47.87 83.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.935 0.789 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -78.8 -3.13 42.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.148 0.885 . . . . 0.0 111.105 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 t30 48.73 63.71 1.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.79 2.036 . . . . 0.0 110.688 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.7 112.15 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.898 2.079 . . . . 0.0 106.851 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -75.33 168.18 20.5 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -67.9 167.67 13.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.323 0.649 . . . . 0.0 110.688 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 50.18 28.94 3.33 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.469 2.308 . . . . 0.0 111.614 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.86 178.41 2.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.907 1.283 . . . . 0.0 108.563 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.1 m -142.59 119.9 11.57 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.9 160.22 15.92 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -119.84 121.35 38.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.074 1.35 . . . . 0.0 107.941 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mt -81.14 131.53 35.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -142.06 -174.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.82 160.26 38.17 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.792 0.806 . . . . 0.0 111.494 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -158.66 150.14 20.84 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 129.415 3.086 . . . . 0.0 104.09 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.5 178.43 5.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -175.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -71.18 172.98 8.26 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.849 0.859 . . . . 0.0 109.63 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.14 2.55 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.707 0.67 . . . . 0.0 112.344 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 N-CA-C 107.324 -2.31 . . . . 0.0 107.324 -179.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -144.0 160.18 41.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.42 161.43 8.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.012 1.325 . . . . 0.0 107.853 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -100.53 141.36 33.51 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.53 106.3 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.349 1.459 . . . . 0.0 107.758 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -78.34 134.08 37.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -103.06 157.52 16.93 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.183 0.593 . . . . 0.0 110.595 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.73 -26.57 61.62 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -65.1 -7.47 12.41 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.101 2.161 . . . . 0.0 113.064 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.84 52.47 2.78 Favored Glycine 0 C--N 1.339 0.717 0 O-C-N 121.341 -0.85 . . . . 0.0 111.612 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -156.45 179.12 9.56 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.689 1.196 . . . . 0.0 109.12 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -139.23 142.22 37.85 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 82.0 mt -127.88 157.82 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.113 1.765 . . . . 0.0 106.772 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 m -124.65 134.01 53.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -130.37 164.13 25.35 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.693 1.197 . . . . 0.0 109.294 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.59 134.26 45.0 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 108.64 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.75 173.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 125.937 1.695 . . . . 0.0 110.837 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -142.0 162.9 43.46 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.289 1.436 . . . . 0.0 109.621 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.05 -30.77 76.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.602 2.201 . . . . 0.0 113.443 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 t -82.85 -11.79 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.559 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.96 124.89 22.01 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.271 1.034 . . . . 0.0 108.711 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 p -69.13 155.83 39.72 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.6 mm -67.4 -28.5 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 118.726 -2.484 . . . . 0.0 109.987 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -58.0 -42.64 85.61 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.261 1.1 t-20 -56.34 -50.65 70.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.579 2.752 . . . . 0.0 111.55 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 43.3 t -67.79 -37.17 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.733 -177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -71.1 -36.92 72.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 120.276 1.398 . . . . 0.0 107.681 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.41 96.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.634 0.774 . . . . 0.0 109.503 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -61.98 -37.3 84.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.818 1.247 . . . . 0.0 110.917 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 tp -80.79 -35.51 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.756 1.616 . . . . 0.0 109.247 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -56.31 -33.29 65.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.099 0.863 . . . . 0.0 108.902 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.1 -27.33 32.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.694 1.597 . . . . 0.0 112.338 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -112.85 -22.12 10.82 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.994 1.318 . . . . 0.0 112.125 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.52 -29.33 24.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.327 0.967 . . . . 0.0 112.734 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.73 48.39 82.08 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.168 0.89 . . . . 0.0 114.67 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 2.5 pp -139.65 168.1 16.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.674 1.99 . . . . 0.0 107.501 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 36' ' ' ILE . 41.5 Cg_endo -84.32 169.5 11.14 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.145 1.897 . . . . 0.0 113.744 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 -30.14 90.1 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.733 2.955 . . . . 0.0 112.107 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.91 165.97 23.92 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.112 0.965 . . . . 0.0 108.998 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 59.08 6.59 0.7 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.711 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -141.28 148.46 39.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 122.299 2.318 . . . . 0.0 111.441 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -150.41 161.64 42.1 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.812 1.645 . . . . 0.0 110.438 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.11 151.91 36.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.097 1.359 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.8 mm -140.01 134.08 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.305 1.442 . . . . 0.0 108.066 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -120.05 100.81 7.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.938 2.095 . . . . 0.0 105.599 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.87 60.68 3.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.985 1.314 . . . . 0.0 109.318 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.22 -21.91 1.69 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.574 1.559 . . . . 0.0 114.643 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -71.27 123.37 22.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.05 1.925 . . . . 0.0 107.189 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -78.83 144.42 35.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -128.48 137.32 51.74 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.654 0.661 . . . . 0.0 112.38 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.38 168.79 26.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.979 1.712 . . . . 0.0 108.216 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.99 160.74 20.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.335 1.454 . . . . 0.0 113.916 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.75 3.3 37.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.552 2.025 . . . . 0.0 112.585 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -143.81 -171.11 3.47 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.841 2.856 . . . . 0.0 109.249 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.1 p -123.95 172.7 8.74 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.38 1.472 . . . . 0.0 110.154 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -33.41 73.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.923 0.889 . . . . 0.0 109.002 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -71.84 -40.75 68.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.224 1.41 . . . . 0.0 110.93 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.91 -48.47 81.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -75.39 0.35 17.21 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t30 44.97 64.83 1.25 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.539 2.736 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.6 mt -101.33 118.83 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -79.1 161.62 26.38 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -70.06 162.75 27.62 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 52.77 31.35 10.35 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.566 1.546 . . . . 0.0 111.487 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 p -73.42 174.85 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.356 1.462 . . . . 0.0 107.721 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 m -134.43 104.23 6.03 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.17 161.76 14.95 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.545 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -122.65 118.44 28.14 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.168 1.387 . . . . 0.0 109.251 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.88 128.41 33.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.48 168.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.104 0.962 . . . . 0.0 108.736 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.72 158.97 33.49 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -156.01 125.72 6.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.853 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -155.09 159.32 40.15 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.954 0.902 . . . . 0.0 109.851 178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.556 ' H ' HD13 ' A' ' 73' ' ' LEU . 41.4 ptt85 -82.52 173.13 12.25 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.13 55.31 4.57 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.598 -3.001 . . . . 0.0 105.598 179.448 . . . . . . . . 0 0 . 1 stop_ save_